<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:34.6pt;left:480.6pt;line-height:17.9pt"><span style="font-family:AdvP6EC5,serif;font-size:17.9pt">Reviews</span></p>
<p style="top:106.2pt;left:145.2pt;line-height:17.9pt"><span style="font-family:AdvP6EC0,serif;font-size:17.9pt">Neuroprotective Properties of Vitamin C:</span></p>
<p style="top:126.1pt;left:92.4pt;line-height:17.9pt"><span style="font-family:AdvP6EC0,serif;font-size:17.9pt">A Scoping Review of Pre-Clinical and Clinical Studies</span></p>
<p style="top:174.4pt;left:90.8pt;line-height:10.0pt"><span style="font-family:AdvP2E44,serif;font-size:10.0pt">Lauren Kangisser,</span><sup><span style="font-family:AdvP2E44,serif;font-size:7.0pt">1,</span></sup><sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt">* </span></sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt">Elinor Tan,</span><sup><span style="font-family:AdvP2E44,serif;font-size:7.0pt">1,</span></sup><sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt">* </span></sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt">Rinaldo Bellomo,</span><sup><span style="font-family:AdvP2E44,serif;font-size:7.0pt">1,2</span></sup><sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt">Adam M. Deane,</span><sup><span style="font-family:AdvP2E44,serif;font-size:7.0pt">1,2</span></sup><sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvP2E44,serif;font-size:10.0pt">and Mark P. Plummer</span><sup><span style="font-family:AdvP2E44,serif;font-size:7.0pt">1,2</span></sup></p>
<p style="top:228.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Abstract</span></p>
<p style="top:243.9pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">There is a need for novel neuroprotective therapies. We aimed to review the evidence for exogenous vitamin C as a</span></p>
<p style="top:255.8pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">neuroprotective agent. MEDLINE, Embase, and Cochrane library databases were searched from inception to May 2020.</span></p>
<p style="top:267.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">Pre-clinical and clinical reports evaluating vitamin C for acute neurological injury were included. Twenty-two pre-clinical</span></p>
<p style="top:279.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">and 11 clinical studies were eligible for inclusion. Pre-clinical studies included models of traumatic and hypoxic brain</span></p>
<p style="top:291.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">injury, subarachnoid and intracerebral hemorrhage, and ischemic stroke. The median [IQR] maximum daily dose of</span></p>
<p style="top:303.6pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">vitamin C in animal studies was 120 [50&#x2013;500] mg/kg. Twenty-one animal studies reported improvements in biomarkers,</span></p>
<p style="top:315.6pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">functional outcome, or both. Clinical studies included single reports in neonatal hypoxic encephalopathy, traumatic brain</span></p>
<p style="top:327.5pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">injury, and subarachnoid hemorrhage and eight studies in ischemic stroke. The median maximum daily dose of vitamin C</span></p>
<p style="top:339.5pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">was 750 [500&#x2013;1000] mg, or</span><span style="font-family:AdvPi1,serif;font-size:10.0pt"> *</span><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">10 mg/kg for an average-size adult male. Apart from one case series of intracisternal</span></p>
<p style="top:351.4pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">vitamin C administration in subarachnoid hemorrhage, clinical studies reported no patient-centered bene&#xfb01;t. Although pre-</span></p>
<p style="top:363.4pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">clinical trials suggest that exogenous vitamin C improves biomarkers of neuroprotection, functional outcome, and mor-</span></p>
<p style="top:375.3pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">tality, these results have not translated to humans. However, clinical trials used approximately one tenth of the vitamin C</span></p>
<p style="top:387.3pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt">dose of animal studies.</span></p>
<p style="top:412.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Keywords:</span><span style="font-family:AdvPS43EDDE,serif;font-size:10.0pt"> ascorbic acid; neuroprotection; stroke; subarachnoid hemorrhage; traumatic brain injury; vitamin C</span></p>
<p style="top:472.9pt;left:62.0pt;line-height:25.2pt"><span style="font-family:AdvPS3D3A15,serif;font-size:25.2pt">V</span><sup><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Introduction</span></sup></p>
<p style="top:475.1pt;left:80.7pt;line-height:9.0pt"><span style="font-family:AdvPS4A13D7,serif;font-size:9.0pt">itamin C</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">, or ascorbic acid, is an essential micronutrient with</span></p>
<p style="top:486.1pt;left:80.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">a normal plasma concentration of 30&#x2013;80</span><span style="font-family:AdvPSMP10,serif;font-size:9.0pt"> l</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">mol/L.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">1</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ap-</span></p>
<p style="top:497.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">proximately 90% of vitamin C is present in the plasma as</span></p>
<p style="top:508.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ascorbic acid and 10% as dehydroascorbic acid (DHA), the re-</span></p>
<p style="top:518.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">duced form of vitamin C.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">2</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vitamin C is a necessary cofactor in</span></p>
<p style="top:529.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPSSym,serif;font-size:9.0pt">&gt;</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">60 enzyme reactions that control a broad range of vital bio-</span></p>
<p style="top:540.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">chemical reactions.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">1</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Importantly, vitamin C is the primary cir-</span></p>
<p style="top:551.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">culatory antioxidant depleted during oxidative stress and is the</span></p>
<p style="top:562.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">only antioxidant capable of preventing lipoprotein peroxida-</span></p>
<p style="top:573.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tion.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">3</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Brain tissue is highly susceptible to oxidative lipid damage</span></p>
<p style="top:584.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">because of its large oxygen demand and high content of poly-</span></p>
<p style="top:595.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">unsaturated fatty acid.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">1</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In health, vitamin C concentrations are</span></p>
<p style="top:606.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">80 times greater in brain cells and 4 times greater in cerebro-</span></p>
<p style="top:617.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">spinal &#xfb02;uid compared to plasma, driven by active transport.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">4</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">This</span></p>
<p style="top:628.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">active concentration of vitamin C in the central nervous system is</span></p>
<p style="top:639.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">thought to be an evolutionary adaptation to protect against</span></p>
<p style="top:650.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neuronal oxidative stress.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">5</span></sup></p>
<p style="top:661.4pt;left:72.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Humans do not synthesize vitamin C, and, in health, mainte-</span></p>
<p style="top:672.4pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">nance of total body stores is dependent on dietary intake.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">6</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Rapid</span></p>
<p style="top:683.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and substantial vitamin C de&#xfb01;ciency is reported from blood sam-</span></p>
<p style="top:458.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ples obtained after a multitude of neurological insults, including</span></p>
<p style="top:469.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">traumatic brain injury, ischemic stroke, intracerebral hemorrhage,</span></p>
<p style="top:480.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and subarachnoid hemorrhage.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">7&#x2013;10</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Further, the nadir in vitamin C</span></p>
<p style="top:491.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">concentration correlates with worse functional outcome.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">7,8</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">This fall</span></p>
<p style="top:502.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">in antioxidant capacity parallels an overwhelming increase in free</span></p>
<p style="top:513.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">radicals and reactive oxygen species, which is thought to be central</span></p>
<p style="top:524.4pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">to the pathogenesis of these neurological insults.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">11</span></sup></p>
<p style="top:535.4pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Systematic reviews have focused on the possible ef&#xfb01;cacy of</span></p>
<p style="top:546.4pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supplementing vitamin C during excessive oxidative stress in</span></p>
<p style="top:557.3pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">sepsis, cancer, and post-cardiac arrest.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">12&#x2013;14</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">However, there has</span></p>
<p style="top:568.3pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">been no comprehensive review of the possible neuroprotective</span></p>
<p style="top:579.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">properties of vitamin C. Accordingly, we aimed to systematically</span></p>
<p style="top:590.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">review all currently available reports of the therapeutic properties</span></p>
<p style="top:601.1pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">of exogenous vitamin C after acute neurological insults.</span></p>
<p style="top:631.4pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Methods</span></p>
<p style="top:647.8pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Study design</span></p>
<p style="top:663.5pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">We conducted a systematically structured scoping review using</span></p>
<p style="top:673.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">the guidelines from the Cochrane Collaboration and Centre for</span></p>
<p style="top:683.4pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Reviews and Dissemination and reported the results according to</span></p>
<p style="top:708.7pt;left:71.0pt;line-height:5.6pt"><span style="font-family:AdvPS43EDDE,serif;font-size:5.6pt">1</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Department of Intensive Care, Royal Melbourne Hospital, Parkville, Victoria, Australia.</span></p>
<p style="top:717.7pt;left:71.0pt;line-height:5.6pt"><span style="font-family:AdvPS43EDDE,serif;font-size:5.6pt">2</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Centre for Integrated Critical Care, Department of Medicine and Radiology, University of Melbourne, Melbourne, Victoria, Australia.</span></p>
<p style="top:728.4pt;left:71.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">*These authors contributed equally.</span></p>
<p style="top:35.2pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvP6EC0,serif;font-size:8.0pt">JOURNAL OF NEUROTRAUMA 38:2194&#x2013;2205 (August 15, 2021)</span></p>
<p style="top:44.2pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&#xaa;</span><span style="font-family:AdvP6EC0,serif;font-size:8.0pt"> Mary Ann Liebert, Inc.</span></p>
<p style="top:53.1pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvP6EC0,serif;font-size:8.0pt">DOI: 10.1089/neu.2020.7443</span></p>
<p style="top:749.9pt;left:297.2pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2194</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:59.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">the PRISMA (Preferred Reporting Items for Systematic Reviews</span></p>
<p style="top:69.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and Meta-Analyses) guideline and its extension for scoping</span></p>
<p style="top:79.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">reviews.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">15</span></sup></p>
<p style="top:101.3pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Inclusion and exclusion criteria</span></p>
<p style="top:117.0pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Eligible studies met the following criteria: 1) randomized con-</span></p>
<p style="top:127.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">trolled trials, non-randomized controlled trials (case control or</span></p>
<p style="top:136.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled cohort), observational studies, and case series; 2) study</span></p>
<p style="top:146.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">population was divided into pre-clinical animal models and clinical</span></p>
<p style="top:156.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">studies of adult and pediatric populations; 3) exposure to traumatic</span></p>
<p style="top:166.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">brain injury, hypoxic brain injury, ischemic stroke, intracerebral</span></p>
<p style="top:176.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">hemorrhage, or subarachnoid hemorrhage; and 4) outcomes of</span></p>
<p style="top:186.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neuroprotection were reported after the administration of exoge-</span></p>
<p style="top:196.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">nous vitamin C by any route. Studies that reported the effect of</span></p>
<p style="top:206.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C in combination with other interventions were included.</span></p>
<p style="top:216.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Studies reporting only</span><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt"> in vitro</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> data were excluded. We included</span></p>
<p style="top:226.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">only studies reported in English. No data or publication status re-</span></p>
<p style="top:236.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">strictions were imposed.</span></p>
<p style="top:258.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">De&#xfb01;nition of neuroprotection</span></p>
<p style="top:274.6pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Neuroprotection in this systematic review was de&#xfb01;ned as any</span></p>
<p style="top:284.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome measure that was proposed by the original authors to be</span></p>
<p style="top:294.5pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">favorable to brain function or neurological performance. This in-</span></p>
<p style="top:304.5pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">cluded studies reporting post-mortem pathology, neuroimaging,</span></p>
<p style="top:314.5pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">plasma and cerebrospinal &#xfb02;uid biomarkers, vasospasm, blood&#x2013;</span></p>
<p style="top:324.5pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">brain barrier integrity, functional outcome scores (both animal and</span></p>
<p style="top:334.4pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">human), and mortality.</span></p>
<p style="top:356.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Data sources and search strategy</span></p>
<p style="top:372.5pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">A librarian and two reviewers (L.K. and E.T.) searched MED-</span></p>
<p style="top:382.4pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">LINE (Ovid), EMBASE (Ovid), and Cochrane Library databases</span></p>
<p style="top:392.4pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">from their inception to May 2020. Searches included synonyms and</span></p>
<p style="top:402.4pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">combinations of the following terms: subarachnoid hemorrhage,</span></p>
<p style="top:412.3pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">stroke, traumatic brain injury, and vitamin C. Terms were truncated</span></p>
<p style="top:422.3pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">in order to capture variable terminology. The full search strategies</span></p>
<p style="top:432.2pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">are provided in Supplementary Materials Additional File S1. We</span></p>
<p style="top:442.2pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">applied no language restrictions during the searches. We also re-</span></p>
<p style="top:452.2pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">viewed reference lists of retrieved articles to identify studies not</span></p>
<p style="top:462.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">captured in the primary search.</span></p>
<p style="top:484.5pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Study selection and data extraction</span></p>
<p style="top:500.2pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Two reviewers independently screened titles and abstracts of all</span></p>
<p style="top:510.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">identi&#xfb01;ed studies. Relevant studies were independently evaluated</span></p>
<p style="top:520.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">in full text for eligibility. Disagreements were resolved by con-</span></p>
<p style="top:530.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">sensus or by consultation with a third reviewer (M.P.). Two re-</span></p>
<p style="top:540.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">viewers independently extracted data from included studies using a</span></p>
<p style="top:550.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">standardized data collection form. Extracted information included</span></p>
<p style="top:560.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">study characteristics (author, publication year, design, and sample</span></p>
<p style="top:570.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">size), participant characteristics (species [for pre-clinical studies]),</span></p>
<p style="top:579.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">diagnosis of injury model, dose and route of vitamin C, other in-</span></p>
<p style="top:589.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">terventions in each arm, and metric of neuroprotection. The sup-</span></p>
<p style="top:599.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">plementary &#xfb01;les of all included studies were also examined for the</span></p>
<p style="top:609.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">purposes of data extraction. A meta-analysis of randomized,</span></p>
<p style="top:619.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo-controlled, clinical trials of vitamin C monotherapy was</span></p>
<p style="top:629.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">planned if including at least three studies.</span></p>
<p style="top:652.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Bias and quality assessment</span></p>
<p style="top:667.8pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The methodological quality of the pre-clinical studies was as-</span></p>
<p style="top:677.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">sessed using the Systematic Review Center for Laboratory animal</span></p>
<p style="top:687.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Experimentation (SYRCLE) checklist.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">16</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Risk of bias in human</span></p>
<p style="top:697.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">randomized controlled trials was assessed using the Cochrane risk-</span></p>
<p style="top:707.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">of-bias tool.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">17</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Risk of bias in human non-randomized trials was</span></p>
<p style="top:717.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">assessed using the &#x2018;&#x2018;Risk Of Bias In Non-randomized Studies &#x2013; of</span></p>
<p style="top:727.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Interventions&#x2019;&#x2019; (ROBINS-I) tool.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">18</span></sup></p>
<p style="top:59.0pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Results</span></p>
<p style="top:75.5pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Our search retrieved 1520 citations with 251 full-text articles</span></p>
<p style="top:86.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">assessed for eligibility. After full text extraction, 33 studies (22 pre-</span></p>
<p style="top:97.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">clinical and 11 clinical) met the eligibility criteria (Fig. 1). Char-</span></p>
<p style="top:108.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">acteristics of the included studies are summarized in Tables 1 and 2.</span></p>
<p style="top:119.3pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In studies reporting multiple interventions, only the vitamin C</span></p>
<p style="top:130.3pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(or vitamin C combination therapy) arm is presented.</span></p>
<p style="top:152.2pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Pre-clinical studies</span></p>
<p style="top:168.6pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In21ofthe22trials,vitaminCtherapyimprovedsecondarymarkers</span></p>
<p style="top:179.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">of brain injury, functional outcome, or both (Table 1). Animal studies</span></p>
<p style="top:190.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">included models of hypoxic brain injury,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">19,20</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">intracranial hemor-</span></p>
<p style="top:201.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">rhage,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">21</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ischemic stroke,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">22&#x2013;33</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">subarachnoid hemorrhage,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">34&#x2013;36</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and</span></p>
<p style="top:212.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">traumatic brain injury.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">37&#x2013;40</span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Allofthe studies were shamintervention or</span></p>
<p style="top:223.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo-controlled trials. Dosing regimens are outlined in Table 1. The</span></p>
<p style="top:234.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">median [interquartile range; IQR] daily dose in pre-clinical studies was</span></p>
<p style="top:245.3pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">120 [50&#x2013;500] mg/kg. Six studies administered vitamin C pre-</span></p>
<p style="top:256.3pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">19,20,23,25,26,28</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">two at the time of the insult,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">27,35</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">nine post-</span></p>
<p style="top:267.3pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">22,24,29&#x2013;31,34,36,38,40</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and &#xfb01;ve pre- and post-insult.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">21,32,33,37,39</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The</span></p>
<p style="top:278.2pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">summary of the risk of bias assessment is displayed in Figure 2.</span></p>
<p style="top:300.2pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Hypoxic brain injury</span></p>
<p style="top:316.6pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In neonatal rat models of global hypoxic brain injury, Miura and</span></p>
<p style="top:327.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">colleagues demonstrated that intracisternal vitamin C (up to</span></p>
<p style="top:338.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">5 mg/kg) and intraperitoneal vitamin C (750 mg/kg) decreased</span></p>
<p style="top:349.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neuronal cell death</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">19,20</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(Table 1).</span></p>
<p style="top:371.4pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Intracranial hemorrhage.</span></p>
<p style="top:371.4pt;left:429.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In the only pre-clinical trial re-</span></p>
<p style="top:382.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">porting no improvement with vitamin C, Peeling and colleagues</span></p>
<p style="top:393.3pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">demonstrated no effect of oral vitamin C (up to 120 mg/kg) and E</span></p>
<p style="top:404.2pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supplementation on functional outcome, brain edema, or hematoma</span></p>
<p style="top:415.2pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">size in a murine model of intracranial hemorrhage</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">21</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(Table 1).</span></p>
<p style="top:437.1pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Ischemic stroke.</span></p>
<p style="top:437.1pt;left:394.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">All twelve studies utilizing animal models of</span></p>
<p style="top:448.1pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ischemic stroke reported signi&#xfb01;cant neuroprotective properties of</span></p>
<p style="top:459.1pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C (or its analogues) when given as monotherapy,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">23,25,27,29&#x2013;31</span></sup></p>
<p style="top:470.0pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">as part of a therapeutic cocktail,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">24</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">or both</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">22,26,28,32,33</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(Table 1). The</span></p>
<p style="top:481.0pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">median [IQR] maximum daily dose was 150 [88&#x2013;500] mg/kg.</span></p>
<p style="top:502.9pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Subarachnoid hemorrhage.</span></p>
<p style="top:502.9pt;left:438.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Three studies describe vitamin</span></p>
<p style="top:513.8pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C attenuating vasospasm post&#x2013;subarachnoid hemorrhage at an in-</span></p>
<p style="top:524.8pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tracisternal</span></p>
<p style="top:524.8pt;left:358.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">dose</span></p>
<p style="top:524.8pt;left:382.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">of</span></p>
<p style="top:524.8pt;left:397.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1.2 mg/kg</span></p>
<p style="top:524.8pt;left:440.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and</span></p>
<p style="top:524.8pt;left:461.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">intramuscular</span></p>
<p style="top:524.8pt;left:518.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">dose</span></p>
<p style="top:524.8pt;left:542.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">of</span></p>
<p style="top:535.8pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">120 mg/kg/d</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">34&#x2013;36</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(Table 1).</span></p>
<p style="top:557.7pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Traumatic brain injury.</span></p>
<p style="top:557.7pt;left:420.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">There have been four studies of vi-</span></p>
<p style="top:568.7pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tamin C administration using rat models of traumatic brain injury,</span></p>
<p style="top:579.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">all of which demonstrated improvements in functional outcome</span></p>
<p style="top:590.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(Table 1).</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">37&#x2013;40</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Interpretation of results from the study by Ishaq and</span></p>
<p style="top:601.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">colleagues is limited given that the route of vitamin C is not pre-</span></p>
<p style="top:612.5pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">sented nor is any statistical analysis of survival</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">37</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(Table 1). The</span></p>
<p style="top:623.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">mean (standard deviation) maximum daily dose of vitamin C in the</span></p>
<p style="top:634.4pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">remaining three studies was 333 (144) mg/kg.</span></p>
<p style="top:656.3pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Clinical studies</span></p>
<p style="top:672.7pt;left:320.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In 5 of 11 clinical studies,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41&#x2013;45</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C improved secondary</span></p>
<p style="top:683.7pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">markers of brain injury, including perilesional edema in traumatic</span></p>
<p style="top:694.7pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">brain injury, and markers of oxidative stress after ischemic stroke.</span></p>
<p style="top:705.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">However, these effects did not translate to an improvement in any</span></p>
<p style="top:716.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">patient-centered outcomes. Clinical studies included one random-</span></p>
<p style="top:727.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ized</span></p>
<p style="top:727.6pt;left:334.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled</span></p>
<p style="top:727.6pt;left:378.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">trial</span></p>
<p style="top:727.6pt;left:401.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">in</span></p>
<p style="top:727.6pt;left:416.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neonates</span></p>
<p style="top:727.6pt;left:456.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">after</span></p>
<p style="top:727.6pt;left:480.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">hypoxic</span></p>
<p style="top:727.6pt;left:517.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ischemic</span></p>
<p style="top:35.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">NEUROPROTECTIVE PROPERTIES OF VITAMIN C</span></p>
<p style="top:35.1pt;left:530.1pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2195</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:530.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">encephalopathy,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">46</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">one case series in adult patients after subarach-</span></p>
<p style="top:541.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">noid hemorrhage,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">47</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">one randomized controlled trial in traumatic</span></p>
<p style="top:552.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">brain injury,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and eight studies in ischemic stroke; which included</span></p>
<p style="top:563.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">one observational study, one case-control study, and six randomized</span></p>
<p style="top:574.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled trials.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41&#x2013;44,48&#x2013;51</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vitamin C as ascorbic acid was the only</span></p>
<p style="top:585.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">analogue studied, both as monotherapy</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45,49&#x2013;51</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">or as part of a com-</span></p>
<p style="top:596.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">bination treatment arm.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41&#x2013;44,46&#x2013;48,50</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Oral doses ranged from 200</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">to</span></p>
<p style="top:607.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1000 mg/d,</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">50</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and intravenous doses ranged from 500 mg/d</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45,49</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">to</span></p>
<p style="top:617.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">10 g/d.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">One case series in patients with subarachnoid hemorrhage</span></p>
<p style="top:628.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">infused vitamin C, in combination with the thrombolytic urokinase,</span></p>
<p style="top:639.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">directly into the subarachnoid space by an intracisternal catheter at a</span></p>
<p style="top:650.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">dose of 120 mg/h (2.88 g/d) for 2&#x2013;18 days.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">52</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The median [IQR]</span></p>
<p style="top:661.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">maximum daily dose of vitamin C in adult trials was 750 [500&#x2013;1000]</span></p>
<p style="top:672.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">mg or</span><span style="font-family:AdvPi1,serif;font-size:9.0pt"> *</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">10mg/kg in an average-size adult male.</span></p>
<p style="top:683.7pt;left:72.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The clinical heterogeneity of these studies failed to meet the pre-</span></p>
<p style="top:694.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">de&#xfb01;ned threshold for meta-analysis. The summary of the risk of</span></p>
<p style="top:705.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">bias for the eight randomized controlled trials and two non-</span></p>
<p style="top:716.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">randomized trials are displayed in Figures 3 and 4, respectively.</span></p>
<p style="top:727.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The case series was not subjected to bias assessment.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">47</span></sup></p>
<p style="top:530.3pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Neonatal hypoxic ischemic encephalopathy.</span></p>
<p style="top:530.3pt;left:514.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In a pro-</span></p>
<p style="top:541.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">spective, double-blind, placebo-controlled trial of 60 neona-</span></p>
<p style="top:552.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tes with hypoxic ischemic encephalopathy, intravenous vitamin</span></p>
<p style="top:563.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C (100 mg/kg/d) in combination with ibuprofen had no effect</span></p>
<p style="top:574.1pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">on in&#xfb02;ammatory markers, hospital mortality, or functional</span></p>
<p style="top:585.1pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">46</span></sup></p>
<p style="top:618.0pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Ischemic stroke.</span></p>
<p style="top:618.0pt;left:398.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No human trials have demonstrated any</span></p>
<p style="top:628.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">patient-centered bene&#xfb01;t from oral or intravenous vitamin C in the</span></p>
<p style="top:639.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">management of ischemic stroke. Four randomized controlled trials</span></p>
<p style="top:650.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">utilizing disparate regimens of vitamin C have demonstrated an</span></p>
<p style="top:661.8pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">improvement in plasma markers of oxidative stress.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41&#x2013;44</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In three</span></p>
<p style="top:672.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">randomized controlled trials with low risk of bias, vitamin C failed</span></p>
<p style="top:683.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">to improve neurological or functional outcome both in the acute</span></p>
<p style="top:694.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">setting</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41,51</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and when administered for up to 1 year post-insult.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">48</span></sup></p>
<p style="top:705.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Only one trial administered vitamin C parenterally (500 mg/d).</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">49</span></sup></p>
<p style="top:716.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The median maximum daily dose in trials of oral vitamin C was 500</span></p>
<p style="top:727.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(305&#x2013;500) mg.</span></p>
<img style="position:absolute;transform:matrix(.63993999,0,-0,.6396835,-78.40665,-80.70801)" src="data:image/jpeg;base64,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">
<p style="top:497.8pt;left:245.3pt;line-height:9.0pt"><span style="font-family:AdvPS3D3A15,serif;font-size:9.0pt">FIG. 1.</span></p>
<p style="top:497.8pt;left:282.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PRISMA &#xfb02;ow diagram.</span></p>
<p style="top:35.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2196</span></p>
<p style="top:35.2pt;left:467.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">KANGISSER ET AL.</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:479.5pt;left:72.8pt;line-height:9.0pt"><span style="font-family:AdvPS4A13D7,serif;font-size:9.0pt">Table</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> 1.</span><span style="font-family:AdvPS4A13D7,serif;font-size:9.0pt"> Characteristics of Pre-Clinical Studies</span></p>
<p style="top:636.1pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Design</span></p>
<p style="top:543.7pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Design detail</span></p>
<p style="top:441.0pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Target condition</span></p>
<p style="top:359.2pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Sample size</span></p>
<p style="top:254.0pt;left:93.8pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Vitamin C regimen</span></p>
<p style="top:282.8pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Dose</span></p>
<p style="top:229.6pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Route</span></p>
<p style="top:180.9pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Duration</span></p>
<p style="top:89.4pt;left:109.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Results</span></p>
<p style="top:727.6pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Miura et al.,</span></p>
<p style="top:718.6pt;left:136.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2006</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">19</span></p>
<p style="top:657.4pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C (variable dose) vs. placebo</span></p>
<p style="top:449.0pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Hypoxic brain injury</span></p>
<p style="top:361.7pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">50 rats</span></p>
<p style="top:303.5pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">0.04, 0.2, 1, or</span></p>
<p style="top:294.5pt;left:137.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">5 mg/kg</span></p>
<p style="top:233.3pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IC</span></p>
<p style="top:194.4pt;left:128.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once pre-insult</span></p>
<p style="top:124.2pt;left:127.2pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Neuronal cell death</span></p>
<p style="top:727.6pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Miura et al.,</span></p>
<p style="top:718.6pt;left:156.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2009</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">20</span></p>
<p style="top:657.4pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C vs. placebo</span></p>
<p style="top:449.0pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Hypoxic brain injury</span></p>
<p style="top:361.7pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">32 rats</span></p>
<p style="top:303.5pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">750 mg/kg</span></p>
<p style="top:233.3pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IP</span></p>
<p style="top:194.4pt;left:147.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once pre-insult</span></p>
<p style="top:124.2pt;left:147.1pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Neuronal cell death</span></p>
<p style="top:727.6pt;left:167.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Peeling et al.,</span></p>
<p style="top:718.6pt;left:176.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1998</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">21</span></p>
<p style="top:657.4pt;left:167.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:165.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vit E vs. placebo</span></p>
<p style="top:449.0pt;left:167.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ICH</span></p>
<p style="top:361.7pt;left:167.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">16 rats</span></p>
<p style="top:303.5pt;left:167.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">40 mg/kg BD</span></p>
<p style="top:294.5pt;left:177.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">pre-ICH</span></p>
<p style="top:294.5pt;left:187.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">60 mg/kg BD</span></p>
<p style="top:294.5pt;left:197.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">post-ICH</span></p>
<p style="top:233.3pt;left:167.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:194.4pt;left:167.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2/52 pre-insult</span></p>
<p style="top:185.4pt;left:177.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1/52 post-</span></p>
<p style="top:185.4pt;left:187.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult</span></p>
<p style="top:124.2pt;left:167.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No difference in brain</span></p>
<p style="top:115.2pt;left:177.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">edema or functional</span></p>
<p style="top:115.2pt;left:187.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome</span></p>
<p style="top:727.6pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Allahtavakoli</span></p>
<p style="top:718.6pt;left:215.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">et al., 2015</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">22</span></p>
<p style="top:657.4pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled study</span></p>
<p style="top:579.0pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No Tx vs. Vit C vs. r-tPA vs. Vit</span></p>
<p style="top:570.0pt;left:215.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> r-tPA</span></p>
<p style="top:449.0pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">60 rats</span></p>
<p style="top:303.5pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/kg</span></p>
<p style="top:233.3pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:194.4pt;left:207.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once post-insult</span></p>
<p style="top:124.2pt;left:206.8pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Infarct size, improved</span></p>
<p style="top:115.2pt;left:217.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">functional outcome</span></p>
<p style="top:727.6pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Bemeur et al.,</span></p>
<p style="top:718.6pt;left:235.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2005</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">23</span></p>
<p style="top:657.4pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:225.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Sham</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> hyperglycemia</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> DHA</span></p>
<p style="top:570.0pt;left:235.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vs.Ischemic</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> hyperglycemia</span></p>
<p style="top:570.0pt;left:245.0pt;line-height:9.0pt"><span style="font-family:AdvPSSym,serif;font-size:9.0pt">+</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> DHA vs. Ischemic</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span></p>
<p style="top:570.0pt;left:257.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">hyperglycemia</span></p>
<p style="top:449.0pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">43 rats</span></p>
<p style="top:303.5pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">50 mg/kg</span></p>
<p style="top:233.3pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IP</span></p>
<p style="top:194.4pt;left:227.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once pre-insult</span></p>
<p style="top:124.2pt;left:226.8pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Brain edema during</span></p>
<p style="top:115.2pt;left:237.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">hyperglycemia</span></p>
<p style="top:727.6pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Corbett et al.,</span></p>
<p style="top:718.6pt;left:275.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2015</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">24</span></p>
<p style="top:657.4pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:264.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> simvastatin vs.</span></p>
<p style="top:570.0pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">&#xfb02;uoxetine vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span></p>
<p style="top:570.0pt;left:284.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">simvastatin</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> &#xfb02;uoxetine</span></p>
<p style="top:449.0pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">57 rats</span></p>
<p style="top:303.5pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">20 mg/kg/d</span></p>
<p style="top:233.3pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:194.4pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1/52 post-insult</span></p>
<p style="top:124.2pt;left:267.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved functional</span></p>
<p style="top:115.2pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome (Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span></p>
<p style="top:115.2pt;left:284.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">simvastatin</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span></p>
<p style="top:115.2pt;left:297.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">&#xfb02;uoxetine)</span></p>
<p style="top:727.6pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">De Sales et al.,</span></p>
<p style="top:718.6pt;left:315.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2019</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">25</span></p>
<p style="top:657.4pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C vs. placebo vs. sham</span></p>
<p style="top:449.0pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">12 rats</span></p>
<p style="top:303.5pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">750 mg/kg</span></p>
<p style="top:233.3pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IP</span></p>
<p style="top:194.4pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once pre-insult</span></p>
<p style="top:124.2pt;left:307.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved functional</span></p>
<p style="top:115.2pt;left:317.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome</span></p>
<p style="top:727.6pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ekici et al.,</span></p>
<p style="top:718.6pt;left:335.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2009</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">26</span></p>
<p style="top:657.4pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled study</span></p>
<p style="top:579.0pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Sham vs. No Tx vs. DHA vs.</span></p>
<p style="top:570.0pt;left:334.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">DHA</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vit D</span></p>
<p style="top:449.0pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">35 rats</span></p>
<p style="top:303.5pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">250 mg/kg</span></p>
<p style="top:233.3pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:194.4pt;left:327.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once pre-insult</span></p>
<p style="top:124.2pt;left:326.4pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Lipid peroxidation</span></p>
<p style="top:115.2pt;left:334.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(DHA</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vit D)</span></p>
<p style="top:727.6pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Henry et al.,</span></p>
<p style="top:718.6pt;left:355.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1998</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">27</span></p>
<p style="top:657.4pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C vs. placebo</span></p>
<p style="top:449.0pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">15 monkeys</span></p>
<p style="top:303.5pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/kg</span></p>
<p style="top:233.3pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:194.4pt;left:347.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once peri-insult</span></p>
<p style="top:124.2pt;left:346.3pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Infarct size</span></p>
<p style="top:727.6pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Sinha et al.,</span></p>
<p style="top:718.6pt;left:375.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2001</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">28</span></p>
<p style="top:657.4pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Sham vs. placebo vs. Vit C</span></p>
<p style="top:570.0pt;left:377.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">liposomes vs. Vit E liposomes</span></p>
<p style="top:570.0pt;left:384.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> E liposomes</span></p>
<p style="top:570.0pt;left:396.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vs.empty liposomes</span></p>
<p style="top:449.0pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1089 rats</span></p>
<p style="top:303.5pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">8 mg/kg</span></p>
<p style="top:233.3pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:194.4pt;left:367.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once pre-insult</span></p>
<p style="top:124.2pt;left:366.2pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Cerebral edema (Vit C</span></p>
<p style="top:115.2pt;left:377.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and combination</span></p>
<p style="top:115.2pt;left:387.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">therapy)</span></p>
<p style="top:727.6pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Song et al.,</span></p>
<p style="top:718.6pt;left:415.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2015</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">29</span></p>
<p style="top:657.4pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">DHA vs. placebo</span></p>
<p style="top:449.0pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Not stated,</span></p>
<p style="top:352.8pt;left:416.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">rats</span></p>
<p style="top:303.5pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">100 mg/kg</span></p>
<p style="top:233.3pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IP</span></p>
<p style="top:194.4pt;left:406.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once post-insult</span></p>
<p style="top:124.2pt;left:406.1pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> BBB disruption,</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span></p>
<p style="top:115.2pt;left:416.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">brain edema</span></p>
<p style="top:727.6pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Huang et al.,</span></p>
<p style="top:718.6pt;left:435.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2001</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">30</span></p>
<p style="top:657.4pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C vs. DHA vs. placebo</span></p>
<p style="top:449.0pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">111 mice</span></p>
<p style="top:303.5pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">DHA: 40 mg/kg,</span></p>
<p style="top:294.5pt;left:436.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">250 mg/kg</span></p>
<p style="top:294.5pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPSSym,serif;font-size:9.0pt">+</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/kg</span></p>
<p style="top:294.5pt;left:456.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C:</span></p>
<p style="top:294.5pt;left:466.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">250 mg/kg,</span></p>
<p style="top:294.5pt;left:476.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/kg</span></p>
<p style="top:233.3pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:194.4pt;left:426.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once post-insult</span></p>
<p style="top:124.2pt;left:426.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">DHA:</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> infarct size and</span></p>
<p style="top:115.2pt;left:436.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">improved functional</span></p>
<p style="top:115.2pt;left:446.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcomes</span></p>
<p style="top:115.2pt;left:456.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">VC: no effect</span></p>
<p style="top:727.6pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Mack et al.,</span></p>
<p style="top:718.6pt;left:494.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2006</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">31</span></p>
<p style="top:657.4pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">DHA vs. placebo</span></p>
<p style="top:449.0pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">57 mice</span></p>
<p style="top:303.5pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">50 mg/kg,</span></p>
<p style="top:294.5pt;left:496.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">100 mg/kg,</span></p>
<p style="top:294.5pt;left:506.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">200 mg/kg</span></p>
<p style="top:233.3pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:194.4pt;left:486.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once post-insult</span></p>
<p style="top:124.2pt;left:485.8pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Infarct size,</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> lipid</span></p>
<p style="top:115.2pt;left:496.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">peroxidation</span></p>
<p style="top:70.0pt;left:527.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(</span><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">continued</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">)</span></p>
<p style="top:749.9pt;left:295.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2197</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:422.0pt;left:122.6pt;line-height:9.0pt"><span style="font-family:AdvPS4A13D7,serif;font-size:9.0pt">Table</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> 1. (C</span><span style="font-family:AdvPS4A13D7,serif;font-size:9.0pt">ontinued</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">)</span></p>
<p style="top:636.1pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Design</span></p>
<p style="top:543.7pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Design detail</span></p>
<p style="top:441.0pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Target condition</span></p>
<p style="top:359.2pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Sample size</span></p>
<p style="top:254.0pt;left:141.1pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Vitamin C regimen</span></p>
<p style="top:282.8pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Dose</span></p>
<p style="top:229.6pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Route</span></p>
<p style="top:180.9pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Duration</span></p>
<p style="top:89.4pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Results</span></p>
<p style="top:727.6pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Zamani et al.,</span></p>
<p style="top:718.6pt;left:183.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2013</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">32</span></p>
<p style="top:657.4pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Intact control vs. No Tx vs.</span></p>
<p style="top:570.0pt;left:185.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo vs.Vit C vs. A1</span></p>
<p style="top:570.0pt;left:195.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">agonist vs. A1 antagonist vs.</span></p>
<p style="top:570.0pt;left:202.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> A1 agonist vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span></p>
<p style="top:570.0pt;left:215.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">A1 antagonist</span></p>
<p style="top:449.0pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">56 mice</span></p>
<p style="top:303.5pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">100 mg/kg</span></p>
<p style="top:233.3pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IP</span></p>
<p style="top:194.4pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1/52 pre-insult</span></p>
<p style="top:185.4pt;left:185.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">(Vit C only)</span></p>
<p style="top:185.4pt;left:195.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1/52 post-</span></p>
<p style="top:185.4pt;left:205.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult (other)</span></p>
<p style="top:124.2pt;left:175.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved functional</span></p>
<p style="top:115.2pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome,</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> neuronal</span></p>
<p style="top:115.2pt;left:195.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">cell death</span></p>
<p style="top:727.6pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Zamani et al.,</span></p>
<p style="top:718.6pt;left:233.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2013</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">33</span></p>
<p style="top:657.4pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled study</span></p>
<p style="top:579.0pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No Tx vs. sham vs. Vit C vs. A1</span></p>
<p style="top:570.0pt;left:232.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">agonist vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> A1 agonist</span></p>
<p style="top:570.0pt;left:242.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> A1 antagonist</span></p>
<p style="top:570.0pt;left:255.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C post-insult vs. Vit C</span></p>
<p style="top:570.0pt;left:262.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">pre-</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> post-insult</span></p>
<p style="top:449.0pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:361.7pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">63 mice</span></p>
<p style="top:303.5pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">100 mg/kg</span></p>
<p style="top:233.3pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IP</span></p>
<p style="top:194.4pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2/52 pre-insult</span></p>
<p style="top:185.4pt;left:235.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1/52 post-</span></p>
<p style="top:185.4pt;left:245.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult</span></p>
<p style="top:124.2pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved functional</span></p>
<p style="top:115.2pt;left:234.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome,</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> neuronal</span></p>
<p style="top:115.2pt;left:245.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">cell death</span></p>
<p style="top:727.6pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Kameda et al.,</span></p>
<p style="top:718.6pt;left:283.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2012</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">34</span></p>
<p style="top:657.4pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled study</span></p>
<p style="top:579.0pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Intact control vs. No Tx vs.</span></p>
<p style="top:570.0pt;left:284.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">thrombin inhibitor vs. Vit C</span></p>
<p style="top:570.0pt;left:292.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> thrombin inhibitor</span></p>
<p style="top:449.0pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">SAH</span></p>
<p style="top:361.7pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Not stated,</span></p>
<p style="top:352.8pt;left:284.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">rabbits</span></p>
<p style="top:303.5pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1.2 mg/kg</span></p>
<p style="top:233.3pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IC</span></p>
<p style="top:194.4pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Day 0 and day 2</span></p>
<p style="top:185.4pt;left:284.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">post-insult</span></p>
<p style="top:124.2pt;left:274.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved vascular</span></p>
<p style="top:115.2pt;left:282.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">reactivity (Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span></p>
<p style="top:115.2pt;left:294.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">thrombin inhibitor)</span></p>
<p style="top:727.6pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Kawakami</span></p>
<p style="top:718.6pt;left:313.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">et al., 1991</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">35</span></p>
<p style="top:657.4pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled study</span></p>
<p style="top:579.0pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Oxy-Hb vs. Vit C&#x2013;treated</span></p>
<p style="top:570.0pt;left:314.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Oxy-Hb</span></p>
<p style="top:449.0pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">SAH</span></p>
<p style="top:361.7pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Not stated,</span></p>
<p style="top:352.8pt;left:314.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">dogs</span></p>
<p style="top:303.5pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">N/A</span></p>
<p style="top:233.3pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IC</span></p>
<p style="top:194.4pt;left:304.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once</span></p>
<p style="top:124.2pt;left:304.0pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vasoconstriction no.</span></p>
<p style="top:727.6pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Li et al., 2011</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">36</span></p>
<p style="top:657.4pt;left:324.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled study</span></p>
<p style="top:579.0pt;left:324.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Intact control vs. No Tx vs. Vit C</span></p>
<p style="top:570.0pt;left:332.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vs. Insulin vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> insulin</span></p>
<p style="top:449.0pt;left:324.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">SAH</span></p>
<p style="top:361.7pt;left:324.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">65 rabbits</span></p>
<p style="top:303.5pt;left:324.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">40 mg/kg TDS</span></p>
<p style="top:233.3pt;left:324.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IM</span></p>
<p style="top:194.4pt;left:324.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">5 days post-</span></p>
<p style="top:185.4pt;left:334.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult</span></p>
<p style="top:124.2pt;left:322.3pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vasospasm (Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span></p>
<p style="top:115.2pt;left:334.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insulin)</span></p>
<p style="top:727.6pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ishaq et al.,</span></p>
<p style="top:718.6pt;left:352.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2013</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">37</span></p>
<p style="top:657.4pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Intact control vs. placebo vs. Vit</span></p>
<p style="top:570.0pt;left:352.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C vs. Vit E vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> E</span></p>
<p style="top:449.0pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">TBI</span></p>
<p style="top:361.7pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">72 rats</span></p>
<p style="top:303.5pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">45 mg/kg,</span></p>
<p style="top:294.5pt;left:354.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">60 mg/kg</span></p>
<p style="top:233.3pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Unclear</span></p>
<p style="top:194.4pt;left:344.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2/52 pre- and</span></p>
<p style="top:185.4pt;left:354.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">post-insult</span></p>
<p style="top:124.2pt;left:343.9pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">[</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Survival (synergistic</span></p>
<p style="top:115.2pt;left:354.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">with Vit E)</span></p>
<p style="top:727.6pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Lin et al.,</span></p>
<p style="top:718.6pt;left:372.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2010</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">38</span></p>
<p style="top:657.4pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Intact control vs. placebo vs. Vit</span></p>
<p style="top:570.0pt;left:374.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C vs. Vit E vs. NOS inhibitor</span></p>
<p style="top:570.0pt;left:384.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vs. apocynin vs. allopurinol</span></p>
<p style="top:449.0pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">TBI</span></p>
<p style="top:361.7pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">72 rats</span></p>
<p style="top:303.5pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/kg daily</span></p>
<p style="top:233.3pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IP</span></p>
<p style="top:194.4pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Up to 3 months</span></p>
<p style="top:124.2pt;left:364.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved functional</span></p>
<p style="top:115.2pt;left:373.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome,</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> BBB</span></p>
<p style="top:115.2pt;left:384.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">disruption</span></p>
<p style="top:727.6pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Maekawa et al.,</span></p>
<p style="top:718.6pt;left:402.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2020</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">39</span></p>
<p style="top:657.4pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled study</span></p>
<p style="top:579.0pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Stabilized Vit C pre- and</span></p>
<p style="top:570.0pt;left:404.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">post-insult vs. Stabilized</span></p>
<p style="top:570.0pt;left:414.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C post-insult vs. control</span></p>
<p style="top:449.0pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">TBI</span></p>
<p style="top:361.7pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">30 rats</span></p>
<p style="top:303.5pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">250 mg/kg/d</span></p>
<p style="top:233.3pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:194.4pt;left:392.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">3 days pre-</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> 7</span></p>
<p style="top:185.4pt;left:404.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">days post-</span></p>
<p style="top:185.4pt;left:414.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult</span></p>
<p style="top:185.4pt;left:424.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">7 days post-</span></p>
<p style="top:185.4pt;left:434.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult</span></p>
<p style="top:124.2pt;left:394.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved functional</span></p>
<p style="top:115.2pt;left:404.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome (prophylactic</span></p>
<p style="top:115.2pt;left:414.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">arm only)</span></p>
<p style="top:727.6pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Wang et al.,</span></p>
<p style="top:718.6pt;left:452.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2014</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">40</span></p>
<p style="top:657.4pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Placebo controlled</span></p>
<p style="top:579.0pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Sham vs. No Tx vs. Vit C vs.</span></p>
<p style="top:570.0pt;left:451.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">statin vs. Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> statin</span></p>
<p style="top:449.0pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">TBI</span></p>
<p style="top:361.7pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">30 rats</span></p>
<p style="top:303.5pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">20 mg/kg/d</span></p>
<p style="top:233.3pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:194.4pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">3 days post-</span></p>
<p style="top:185.4pt;left:454.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">insult</span></p>
<p style="top:124.2pt;left:444.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Improved functional</span></p>
<p style="top:115.2pt;left:454.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome</span></p>
<p style="top:720.4pt;left:473.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">BBB, blood&#x2013;brain barrier; DHA, dehydroascorbic acid; IC, intracisternal; ICH, intracranial hemorrhage; IM, intramuscular; IP, intraperitoneal; IV, intravenous; N/A, not applicable; NOS, nitric oxide synthase; PO, per</span></p>
<p style="top:728.4pt;left:482.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">oral; r-tPA, reverse tissue plasminogen activator; SAH, subarachnoid hemorrhage; TBI, traumatic brain injury; Tx, treatment; VC, vitamin C.</span></p>
<p style="top:749.9pt;left:297.2pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2198</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:471.0pt;left:87.0pt;line-height:9.0pt"><span style="font-family:AdvPS4A13D7,serif;font-size:9.0pt">Table</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> 2.</span><span style="font-family:AdvPS4A13D7,serif;font-size:9.0pt"> Characteristics of Clinical Studies</span></p>
<p style="top:634.3pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Design</span></p>
<p style="top:559.7pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Design details</span></p>
<p style="top:463.4pt;left:113.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Target</span></p>
<p style="top:468.4pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">condition</span></p>
<p style="top:411.2pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Sample size</span></p>
<p style="top:293.1pt;left:108.0pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Vitamin C regimen</span></p>
<p style="top:337.3pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Dose</span></p>
<p style="top:287.9pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Route</span></p>
<p style="top:255.1pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Frequency</span></p>
<p style="top:198.1pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Duration</span></p>
<p style="top:101.3pt;left:123.4pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Results</span></p>
<p style="top:727.6pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Aly et al.,</span></p>
<p style="top:718.6pt;left:150.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2009</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">46</span></p>
<p style="top:657.4pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized,</span></p>
<p style="top:648.5pt;left:152.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">double-blind,</span></p>
<p style="top:648.5pt;left:162.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo-</span></p>
<p style="top:648.5pt;left:172.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled trial</span></p>
<p style="top:575.3pt;left:139.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> ibuprofen vs.</span></p>
<p style="top:566.4pt;left:152.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo</span></p>
<p style="top:481.3pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Neonatal HIE</span></p>
<p style="top:392.0pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">60</span></p>
<p style="top:358.0pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">100 mg/kg/d</span></p>
<p style="top:283.1pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:256.5pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">3 days</span></p>
<p style="top:148.0pt;left:142.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No difference in neurological</span></p>
<p style="top:139.1pt;left:152.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome</span></p>
<p style="top:727.6pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Garbagnati</span></p>
<p style="top:718.6pt;left:190.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">et al., 2009</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">48</span></p>
<p style="top:657.4pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized,</span></p>
<p style="top:648.5pt;left:192.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">double-blind,</span></p>
<p style="top:648.5pt;left:202.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo-</span></p>
<p style="top:648.5pt;left:212.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled trial</span></p>
<p style="top:575.3pt;left:178.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Antioxidant</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">a</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> vs. fatty</span></p>
<p style="top:566.4pt;left:192.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">acid vs. fatty acid,</span></p>
<p style="top:566.4pt;left:198.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">antioxidant</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">a</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> vs.</span></p>
<p style="top:566.4pt;left:212.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo</span></p>
<p style="top:481.3pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:392.0pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">72</span></p>
<p style="top:358.0pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">240 mg/d</span></p>
<p style="top:283.1pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:256.5pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">12 months</span></p>
<p style="top:148.0pt;left:182.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No effect in neurological or</span></p>
<p style="top:139.1pt;left:192.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">functional outcome</span></p>
<p style="top:727.6pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Lagowska-</span></p>
<p style="top:718.6pt;left:231.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Lenard et al.,</span></p>
<p style="top:718.6pt;left:240.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2010</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">49</span></p>
<p style="top:657.4pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Controlled clinical</span></p>
<p style="top:648.5pt;left:231.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">trial</span></p>
<p style="top:575.3pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C vs. no</span></p>
<p style="top:566.4pt;left:231.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supplementation</span></p>
<p style="top:481.3pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:392.0pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">60</span></p>
<p style="top:358.0pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/d</span></p>
<p style="top:283.1pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:256.5pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">10 days</span></p>
<p style="top:148.0pt;left:221.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No effect on functional outcome</span></p>
<p style="top:139.1pt;left:231.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">at 3 months</span></p>
<p style="top:727.6pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Polidori et al.,</span></p>
<p style="top:718.6pt;left:259.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2005</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41</span></p>
<p style="top:657.4pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized, open-</span></p>
<p style="top:648.5pt;left:261.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">label clinical</span></p>
<p style="top:648.5pt;left:271.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">trial</span></p>
<p style="top:575.3pt;left:249.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> aspirin vs.</span></p>
<p style="top:566.4pt;left:261.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">aspirin only</span></p>
<p style="top:481.3pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:392.0pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">59</span></p>
<p style="top:358.0pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">200 mg/d</span></p>
<p style="top:283.1pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:256.5pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:251.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">90 days</span></p>
<p style="top:148.0pt;left:251.0pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Lipid peroxidation</span></p>
<p style="top:139.1pt;left:261.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No difference in functional</span></p>
<p style="top:139.1pt;left:271.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome</span></p>
<p style="top:727.6pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Rabadi et al.,</span></p>
<p style="top:718.6pt;left:289.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2007</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">50</span></p>
<p style="top:657.4pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Retrospective case-</span></p>
<p style="top:648.5pt;left:291.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">control study</span></p>
<p style="top:575.3pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C vs. no</span></p>
<p style="top:566.4pt;left:291.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supplementation</span></p>
<p style="top:481.3pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:392.0pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">46</span></p>
<p style="top:358.0pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1000 mg/d</span></p>
<p style="top:283.1pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:256.5pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Not reported</span></p>
<p style="top:148.0pt;left:281.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No difference in functional</span></p>
<p style="top:139.1pt;left:291.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome or disposition</span></p>
<p style="top:727.6pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Rabl et al.,</span></p>
<p style="top:718.6pt;left:309.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1996</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">44</span></p>
<p style="top:657.4pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized,</span></p>
<p style="top:648.5pt;left:311.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo-</span></p>
<p style="top:648.5pt;left:321.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled study</span></p>
<p style="top:575.3pt;left:297.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Omnibionta</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">c</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> vs.</span></p>
<p style="top:566.4pt;left:311.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo</span></p>
<p style="top:481.3pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Carotid artery</span></p>
<p style="top:472.4pt;left:311.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">surgery</span></p>
<p style="top:392.0pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">57</span></p>
<p style="top:358.0pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1000 mg</span></p>
<p style="top:283.1pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:256.5pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once</span></p>
<p style="top:204.8pt;left:301.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Once</span></p>
<p style="top:148.1pt;left:300.8pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Markers of oxidative stress</span></p>
<p style="top:139.1pt;left:311.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and headache</span></p>
<p style="top:727.6pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Rumyantseva</span></p>
<p style="top:718.6pt;left:339.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">et al., 2017</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">51</span></p>
<p style="top:657.4pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized</span></p>
<p style="top:648.5pt;left:341.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled trial</span></p>
<p style="top:575.3pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C vs. Cyto&#xfb02;avin</span></p>
<p style="top:566.4pt;left:341.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">for 10/20 days</span></p>
<p style="top:481.3pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:396.5pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">373</span></p>
<p style="top:358.0pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1000 mg/d</span></p>
<p style="top:283.1pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:256.5pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:331.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Not reported</span></p>
<p style="top:148.0pt;left:330.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Cyto&#xfb02;avin</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> infarct size and</span></p>
<p style="top:139.1pt;left:341.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">improved functional outcome</span></p>
<p style="top:727.6pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ullegaddi et al.,</span></p>
<p style="top:718.6pt;left:359.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2005</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">42</span></p>
<p style="top:657.4pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized</span></p>
<p style="top:648.5pt;left:361.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled trial</span></p>
<p style="top:575.3pt;left:348.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vit E vs. no</span></p>
<p style="top:566.4pt;left:361.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supplementation</span></p>
<p style="top:481.3pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:392.0pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">48</span></p>
<p style="top:358.0pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/d</span></p>
<p style="top:283.1pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:256.5pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:351.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">14 days</span></p>
<p style="top:148.0pt;left:350.6pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Markers of oxidative stress</span></p>
<p style="top:139.1pt;left:361.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and in&#xfb02;ammation</span></p>
<p style="top:727.6pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ullegaddi et al.,</span></p>
<p style="top:718.6pt;left:379.5pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2006</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">43</span></p>
<p style="top:657.4pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized</span></p>
<p style="top:648.5pt;left:381.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled trial</span></p>
<p style="top:575.3pt;left:368.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vit E vs. Vit C</span></p>
<p style="top:566.4pt;left:378.8pt;line-height:9.0pt"><span style="font-family:AdvPSSym,serif;font-size:9.0pt">+</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vit E</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Vit B</span></p>
<p style="top:566.4pt;left:387.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">group</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">b</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> vs. Vit B</span></p>
<p style="top:566.4pt;left:397.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">group</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">b</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> vs. no</span></p>
<p style="top:566.4pt;left:411.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supplementation</span></p>
<p style="top:481.3pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ischemic stroke</span></p>
<p style="top:392.0pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">92</span></p>
<p style="top:358.0pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/d</span></p>
<p style="top:283.1pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">PO</span></p>
<p style="top:256.5pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">14 days</span></p>
<p style="top:148.1pt;left:370.5pt;line-height:9.0pt"><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt">Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> Markers of oxidative stress</span></p>
<p style="top:139.1pt;left:381.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and in&#xfb02;ammation</span></p>
<p style="top:727.6pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Kodama et al.,</span></p>
<p style="top:718.6pt;left:429.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2000</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">47</span></p>
<p style="top:657.4pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Observational</span></p>
<p style="top:648.5pt;left:431.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">study</span></p>
<p style="top:575.3pt;left:418.6pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> urokinase</span></p>
<p style="top:481.3pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">SAH</span></p>
<p style="top:396.5pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">217</span></p>
<p style="top:358.0pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">4 mg/mL at</span></p>
<p style="top:349.0pt;left:431.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">30 mL/h</span></p>
<p style="top:283.1pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">CI</span></p>
<p style="top:256.5pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Continuous</span></p>
<p style="top:204.8pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2&#x2013;18 days</span></p>
<p style="top:148.0pt;left:421.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vasospasm incidence 3%,</span></p>
<p style="top:139.1pt;left:431.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">mortality 3%</span></p>
<p style="top:727.6pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Razmkon et al.,</span></p>
<p style="top:718.6pt;left:449.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">2011</span><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45</span></p>
<p style="top:657.4pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Randomized,</span></p>
<p style="top:648.5pt;left:451.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">double-blind,</span></p>
<p style="top:648.5pt;left:461.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">placebo-</span></p>
<p style="top:648.5pt;left:471.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">controlled trial</span></p>
<p style="top:575.3pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C (low dose) vs.</span></p>
<p style="top:566.4pt;left:451.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit C (high dose) vs.</span></p>
<p style="top:566.4pt;left:461.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Vit E vs. placebo</span></p>
<p style="top:481.3pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">TBI</span></p>
<p style="top:396.5pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">100</span></p>
<p style="top:358.0pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">500 mg/d vs.</span></p>
<p style="top:349.0pt;left:451.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">4&#x2013;10 g/d</span></p>
<p style="top:283.1pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">IV</span></p>
<p style="top:256.5pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Daily</span></p>
<p style="top:204.8pt;left:441.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">7 days</span></p>
<p style="top:148.1pt;left:440.2pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">High-dose Vit C</span><span style="font-family:AdvPS40C6FB,serif;font-size:9.0pt"> Y</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> perilesional</span></p>
<p style="top:139.1pt;left:451.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">edema</span></p>
<p style="top:722.2pt;left:487.6pt;line-height:5.6pt"><span style="font-family:AdvPS43EDDE,serif;font-size:5.6pt">a</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Vit C (240 mg)</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> Vit E (290 mg)</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> polyphenols (150 mg)</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> +</span><span style="font-family:AdvPSMP10,serif;font-size:8.0pt"> b</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">-carotene (19 mg)</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> n-3 polyunsaturated fatty acid (500 mg).</span></p>
<p style="top:722.2pt;left:496.6pt;line-height:5.6pt"><span style="font-family:AdvPS43EDDE,serif;font-size:5.6pt">b</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Vit B9 (5 mg)</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> Vit B2 (5 mg)</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> Vit 6 (50 mg)</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> +</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> Vit B12 (0.4 mg).</span></p>
<p style="top:722.2pt;left:506.1pt;line-height:5.6pt"><span style="font-family:AdvPS43EDDE,serif;font-size:5.6pt">c</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Multi-vitamin: Vit B groups, C, and E.</span></p>
<p style="top:720.4pt;left:516.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">CI, cisternal irrigation; HIE, hypoxic ischemic encephalopathy; IV, intravenous; PO, per oral; SAH, subarachnoid haemorrhage; TBI, traumatic brain injury.</span></p>
<p style="top:749.9pt;left:295.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2199</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<img style="position:absolute;transform:matrix(.63993999,0,-0,.63984796,-78.40665,-214.87537)" src="data:image/jpeg;base64,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">
<p style="top:726.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS3D3A15,serif;font-size:9.0pt">FIG. 2.</span></p>
<p style="top:726.8pt;left:99.3pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Risk of bias in pre-clinical studies. Risk of bias was assessed using the Systematic Review Center for Laboratory animal</span></p>
<p style="top:736.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Experimentation (SYRCLE) checklist.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">16</span></sup></p>
<p style="top:749.9pt;left:297.2pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2200</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:407.9pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Subarachnoid hemorrhage.</span></p>
<p style="top:407.9pt;left:187.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The only human data on ther-</span></p>
<p style="top:418.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">apeutic vitamin C in subarachnoid hemorrhage comes from a</span></p>
<p style="top:429.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">single-center (Fukushima, Japan) case series of 217 patients with</span></p>
<p style="top:440.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">subarachnoid hemorrhage over a 14-year period from 1984 to</span></p>
<p style="top:451.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1998.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">47</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The authors describe their local practice of routine use of</span></p>
<p style="top:462.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">cisternal irrigation therapy to prevent vasospasm after clipping of</span></p>
<p style="top:473.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ruptured aneurysms. The local technique involved an irrigation</span></p>
<p style="top:484.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">catheter inserted into the Sylvian &#xfb01;ssure and a solution of Ringer&#x2019;s</span></p>
<p style="top:407.9pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">lactate with urokinase (120 IU/mL) and vitamin C (4 mg/mL) in-</span></p>
<p style="top:418.9pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">fused at 30 mL/h for 2&#x2013;18 days (mean, 9.9).</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">47</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The contempora-</span></p>
<p style="top:429.9pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neous incidence of symptomatic vasospasm after subarachnoid</span></p>
<p style="top:440.8pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">hemorrhage in the late 1980s was 32.5%, of which 34% developed</span></p>
<p style="top:451.8pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">permanent neurological de&#xfb01;cits and 30% died.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">53</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The authors re-</span></p>
<p style="top:462.8pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ported a low rate of vasospasm (2.8%), with 1 patient (0.4%) de-</span></p>
<p style="top:473.7pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">veloping a permanent neurological de&#xfb01;cit and no patients dying</span></p>
<p style="top:484.7pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">from complications of vasospasm.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">47</span></sup></p>
<img style="position:absolute;transform:matrix(.6399397,0,-0,.6392125,30.689332,-35.778657)" src="data:image/jpeg;base64,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">
<p style="top:376.2pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS3D3A15,serif;font-size:9.0pt">FIG. 3.</span></p>
<p style="top:376.2pt;left:95.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Risk of bias in human randomized controlled trials. Risk of bias in human randomized controlled trials was assessed using the</span></p>
<p style="top:386.2pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Cochrane risk-of-bias tool.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">17</span></sup></p>
<img style="position:absolute;transform:matrix(.6399392,0,-0,.6390984,-31.37732,599.8401)" src="data:image/jpeg;base64,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">
<p style="top:717.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS3D3A15,serif;font-size:9.0pt">FIG. 4.</span></p>
<p style="top:717.6pt;left:96.4pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Risk of bias in human non-randomized trials. Risk of bias in human non-randomized trials was assessed using the &#x2018;&#x2018;Risk Of</span></p>
<p style="top:727.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Bias In Non-randomized Studies &#x2013; of Interventions (ROBINS-I)&#x2019;&#x2019; tool.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">18</span></sup></p>
<p style="top:35.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">NEUROPROTECTIVE PROPERTIES OF VITAMIN C</span></p>
<p style="top:35.1pt;left:530.1pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2201</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:59.0pt;left:72.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC0,serif;font-size:9.0pt">Traumatic brain injury.</span></p>
<p style="top:59.0pt;left:173.9pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In the only trial of vitamin C in</span></p>
<p style="top:70.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">traumatic brain injury, investigators randomized 100 patients with</span></p>
<p style="top:81.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">severe traumatic brain injury to a 7-day regimen of &#x2018;&#x2018;high-dose&#x2019;&#x2019;</span></p>
<p style="top:91.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">intravenous vitamin C, low-dose vitamin C, vitamin E, or place-</span></p>
<p style="top:102.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">bo.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">High-dose intravenous vitamin C (maximum daily dose, 10 g)</span></p>
<p style="top:113.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">decreased perilesional oedema on computed tomography (CT)</span></p>
<p style="top:124.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">imaging, but this did not translate to an improvement in functional</span></p>
<p style="top:135.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outcome.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45</span></sup></p>
<p style="top:157.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Discussion</span></p>
<p style="top:174.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Key &#xfb01;ndings</span></p>
<p style="top:190.6pt;left:72.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">We conducted a systematically structured scoping review to</span></p>
<p style="top:201.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">evaluate whether vitamin C therapy has neuroprotective bene&#xfb01;t</span></p>
<p style="top:212.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">after acute neurological insults. Using an assessment of method-</span></p>
<p style="top:223.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ology, we evaluated both animal model (pre-clinical) and human</span></p>
<p style="top:234.4pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">studies of exogenous vitamin C in the setting of acute neurological</span></p>
<p style="top:245.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">injury. We identi&#xfb01;ed 22 relevant pre-clinical studies and 11 clinical</span></p>
<p style="top:256.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">studies. We describe a pattern of promising observations using pre-</span></p>
<p style="top:267.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">clinical studies of high-dose vitamin C (median dose, 120 mg/kg)</span></p>
<p style="top:278.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">that have not translated to human trials utilizing substantially lesser</span></p>
<p style="top:289.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">doses (median dose,</span><span style="font-family:AdvPi1,serif;font-size:9.0pt"> *</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">10 mg/kg).</span></p>
<p style="top:300.2pt;left:72.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The neutral results from human studies may represent a true</span></p>
<p style="top:311.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">lack of ef&#xfb01;cacy of vitamin C. However, it may also represent</span></p>
<p style="top:322.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">inadequate dosing, particularly given the dosing regimens tested</span></p>
<p style="top:333.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and the known pharmacokinetic pro&#xfb01;le of vitamin C in the criti-</span></p>
<p style="top:344.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">cally ill. Ten of the 11 clinical studies evaluated a daily dose of</span></p>
<p style="top:355.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C of</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> &#xa3;</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">1000 mg/d, which would appear to be insuf&#xfb01;cient to</span></p>
<p style="top:365.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">achieve even physiological plasma concentrations during acute</span></p>
<p style="top:376.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">illness. In a single-center observational study of 44 critically ill</span></p>
<p style="top:387.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">patients, Carr and colleagues reported that 70% of patients had</span></p>
<p style="top:398.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">hypovitaminosis C despite receiving recommended vitamin C</span></p>
<p style="top:409.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supplementation (mean daily intake, 125</span><span style="font-family:AdvPSSym,serif;font-size:9.0pt"> &#x2013;</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> 88 mg/d).</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">54</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In a study</span></p>
<p style="top:420.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">of 57 elective post-operative patients in intensive care, up to 8 g of</span></p>
<p style="top:431.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">intravenous vitamin C over 12 h was required to normalize plasma</span></p>
<p style="top:442.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C levels in the most severely de&#xfb01;cient patients.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">55</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In a</span></p>
<p style="top:453.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">feasibility study of 24 patients, Fowler and collegaues reported</span></p>
<p style="top:464.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">that 50 mg/kg/24 h restored plasma levels to normal within 6 h of</span></p>
<p style="top:475.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">infusion commencement.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">56</span></sup></p>
<p style="top:486.5pt;left:72.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Similarly, in a nested cohort study of 21 patients with septic</span></p>
<p style="top:497.5pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">shock, nearly half of the study cohort had either vitamin C de&#xfb01;ciency</span></p>
<p style="top:508.4pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">or hypovitaminosis C at baseline, and 1.5g of intravenous vitamin C</span></p>
<p style="top:519.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">every 6 h was required to maintain normal or supranormal vitamin C</span></p>
<p style="top:530.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">levels.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">57</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Finally, in a study of vitamin C pharmacokinetics in the</span></p>
<p style="top:541.3pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">critically ill, De Grooth and colleagues described that plasma vitamin</span></p>
<p style="top:552.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C levels could be restored to just above the lower normal threshold</span></p>
<p style="top:563.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">with 2 g of intravenous vitamin C every 12 h (4g/d) and that this</span></p>
<p style="top:574.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">regimen needs to be sustained for at least 48 h.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">58</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Based on these</span></p>
<p style="top:585.1pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">pharmacokinetic data, the 11 human studies that evaluated potential</span></p>
<p style="top:596.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neuroprotective properties of vitamin C have used substantially</span></p>
<p style="top:607.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">lesser doses of vitamin C than are required to reach physiological or</span></p>
<p style="top:618.0pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">supraphysiological concentrations in other critically ill populations.</span></p>
<p style="top:628.9pt;left:72.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Five human trials in ischemic stroke utilized the oral route for vi-</span></p>
<p style="top:639.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tamin C delivery.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">41&#x2013;43,48,50</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">It is now recognized that bolus oral sup-</span></p>
<p style="top:650.9pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">plementation is inadequate to achieve normal or supraphysiological</span></p>
<p style="top:661.8pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">plasma levels of vitamin C in a critically ill population.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">59,60</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">In health,</span></p>
<p style="top:672.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C absorption from the gut is determined by the saturable so-</span></p>
<p style="top:683.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">dium vitamin C transport type 1 protein on the luminal surface of the</span></p>
<p style="top:694.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">enterocyte, such that bioavailability reaches a ceiling effect above an</span></p>
<p style="top:705.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">oraldose of</span><span style="font-family:AdvPi1,serif;font-size:9.0pt"> *</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">200mg.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">61</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">This limited uptake is further compromised in</span></p>
<p style="top:716.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neurocritical illness where disturbances of intestinal function (ileus,</span></p>
<p style="top:727.6pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">malabsorption, constipation, and diarrhea) occur frequently.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">62</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Ac-</span></p>
<p style="top:59.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">cordingly, trials using the oral route were unlikely to have achieved</span></p>
<p style="top:70.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">plasma concentrations to elicit any potential bene&#xfb01;t (or harm).</span></p>
<p style="top:81.0pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The only study utilizing intravenous vitamin C at a dose that is</span></p>
<p style="top:91.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">known to achieve appropriate plasma concentrations in the criti-</span></p>
<p style="top:102.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">cally ill was the randomized, blinded, placebo-controlled trial by</span></p>
<p style="top:113.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Razmkon and colleagues whereby 100 patients with severe trau-</span></p>
<p style="top:124.8pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">matic brain injury were randomized to receive low-dose vitamin C,</span></p>
<p style="top:135.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">high-dose vitamin C, vitamin E, or placebo.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">45</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Patients in the high-</span></p>
<p style="top:146.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">dose arm were administered 10,000 mg of vitamin C intravenously</span></p>
<p style="top:157.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">on days 1 and 4 and 4000 mg on days 5 through 7. The intervention</span></p>
<p style="top:168.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">decreased perilesional edema on CT, but there was no statistically</span></p>
<p style="top:179.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">signi&#xfb01;cant effect on patient-centered outcomes.</span></p>
<p style="top:190.6pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Five of the pre-clinical trials of ischemic stroke administered DHA,</span></p>
<p style="top:201.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">the oxidized form of vitamin C.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">23,26,29&#x2013;31</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Huang and colleagues</span></p>
<p style="top:212.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">demonstrated the superiority of DHA compared to equipotent doses of</span></p>
<p style="top:223.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C in reducing infarct volume and improving functional out-</span></p>
<p style="top:234.4pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">come in a rat model of ischemic stroke.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">30</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The mechanism whereby</span></p>
<p style="top:245.3pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">vitamin C enters the brain is incompletely understood; however, DHA</span></p>
<p style="top:256.3pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">is thought to cross the blood barrier whereas the reduced form,</span></p>
<p style="top:267.3pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ascorbic acid, does not.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">63</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">This unique permeability property offers</span></p>
<p style="top:278.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">mechanistic plausibility that DHA may be superior to ascorbic acid in</span></p>
<p style="top:289.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">acute neurological injury.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">30</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Given these animal data, the potential for</span></p>
<p style="top:300.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">therapeutic use of DHA in human trials merits further investigation.</span></p>
<p style="top:311.1pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">A &#xfb01;nal key difference between the pre-clinical and clinical</span></p>
<p style="top:322.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">studies is the timing of vitamin C delivery. In 13 of the pre-clinical</span></p>
<p style="top:333.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">trials, vitamin C was administered before, or at the time of, the</span></p>
<p style="top:344.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neurological insult. Though not explicitly stated, by virtue of the</span></p>
<p style="top:354.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">animal model study design, trials delivering vitamin C post-insult</span></p>
<p style="top:365.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">would have had a shorter lag time to initiation of therapy than in</span></p>
<p style="top:376.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">clinical trials where resuscitation and consent hamper early thera-</span></p>
<p style="top:387.8pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">py.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">64</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Oxidative stress commences within minutes of an inciting</span></p>
<p style="top:398.8pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">neurological insult and there is face validity that earlier initiation of</span></p>
<p style="top:409.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">antioxidant treatment may be preferable.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">65</span></sup></p>
<p style="top:420.7pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">The single-center case series after subarachnoid hemorrhage re-</span></p>
<p style="top:431.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ported a low incidence of vasospasm and mortality when vitamin C</span></p>
<p style="top:442.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">was infused into the subarachnoid space in patients who had un-</span></p>
<p style="top:453.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">dergone clipping of ruptured intracranial aneurysms.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">47</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">However,</span></p>
<p style="top:464.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">because of the substantive issues with internal validity of these data,</span></p>
<p style="top:475.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">it should not in&#xfb02;uence clinical practice. Interestingly, despite the</span></p>
<p style="top:486.5pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">magnitude of effect reported by the investigators, the use of vitamin</span></p>
<p style="top:497.4pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C in this cohort has not been subjected to subsequent evaluation.</span></p>
<p style="top:524.8pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Implications</span></p>
<p style="top:541.3pt;left:323.0pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Our scoping review implies that there is a signal from pre-clinical</span></p>
<p style="top:552.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">trials that vitamin C may be neuroprotective in acute neurological</span></p>
<p style="top:563.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">injury and improve functional outcome. Moreover, it implies that</span></p>
<p style="top:574.2pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">clinical trials to date have used dosing strategies, which, based on</span></p>
<p style="top:585.1pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">current understanding of pharmacokinetics, would not achieve</span></p>
<p style="top:596.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">physiological plasma concentrations in health, let alone pharmaco-</span></p>
<p style="top:607.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">logical concentrations. The recent publication of four large, ran-</span></p>
<p style="top:618.0pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">domized controlled trials of vitamin C in septic shock (ACTS,</span></p>
<p style="top:628.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">ATESS, CITRUS-ALI, and VITAMINS) supports the rationale for</span></p>
<p style="top:639.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">higher parenteral doses.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">66&#x2013;69</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">These trials compared intravenous vi-</span></p>
<p style="top:650.9pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tamin C, at doses ranging from 6 g/d up to 200 mg/kg/d, to placebo</span></p>
<p style="top:661.8pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">for primary outcomes of time alive and free of vasopressor support</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">66</span></sup></p>
<p style="top:672.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and the change in Sequential Organ Failure Assessment score at 72 or</span></p>
<p style="top:683.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">96h.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">67&#x2013;69</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Recent experimental work in a sheep model of septic shock</span></p>
<p style="top:694.7pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">suggests that much greater doses of vitamin C (4g/kg) has a more</span></p>
<p style="top:705.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">pronounced physiological effect.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">70</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Taken together, these observa-</span></p>
<p style="top:716.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tions imply that prospective clinical trials of high-dose, early vitamin</span></p>
<p style="top:727.6pt;left:313.1pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">C therapy after acute neurological insults are warranted.</span></p>
<p style="top:35.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2202</span></p>
<p style="top:35.2pt;left:467.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">KANGISSER ET AL.</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:59.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6ECA,serif;font-size:9.0pt">Strengths and limitations</span></p>
<p style="top:75.5pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">To our knowledge, this is the &#xfb01;rst systematic review of the neu-</span></p>
<p style="top:86.4pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">roprotective properties of vitamin C therapy. Our review provides a</span></p>
<p style="top:97.4pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">comprehensive assessment of the ef&#xfb01;cacy of vitamin C as a neuro-</span></p>
<p style="top:108.4pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">protective therapy in both pre-clinical</span><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt"> in vivo</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> studies and clinical trials.</span></p>
<p style="top:119.3pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Our review has some limitations. We conducted a scoping re-</span></p>
<p style="top:130.3pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">view without formal meta-analysis. This was because we expected</span></p>
<p style="top:141.2pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">considerable heterogeneity in the dosing regimens and outcome</span></p>
<p style="top:152.2pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">measures across both pre-clinical and clinical trials. This concern</span></p>
<p style="top:163.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">was con&#xfb01;rmed by our review. To increase the breadth of the review,</span></p>
<p style="top:174.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">we included case series and observational studies acknowledging</span></p>
<p style="top:185.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">that these yield a lower level of evidence and these studies had a</span></p>
<p style="top:196.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">higher risk of bias. We assessed both pre-clinical and clinical</span></p>
<p style="top:207.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">studies, and the lack of external validity in translating pre-clinical</span></p>
<p style="top:218.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">research to the bedside is a well-recognized limitation of animal</span></p>
<p style="top:228.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">models of neurological injury.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">71,72</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Rodents have vastly different</span></p>
<p style="top:239.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">brain size and structure, higher function de&#xfb01;cits such as language</span></p>
<p style="top:250.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">and emotion cannot be assessed, brain injury models represent</span></p>
<p style="top:261.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">mild-moderate injury without prolonged periods of coma, and, as</span></p>
<p style="top:272.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">outlined above, the time window for therapeutic intervention is</span></p>
<p style="top:283.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">often hyperacute (or prophylactic).</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">65,71</span></sup><sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Moreover, none of the pre-</span></p>
<p style="top:294.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">clinical studies had a low risk of bias. Finally, we only included</span></p>
<p style="top:305.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">studies in the English language and excluded 18 articles written in</span></p>
<p style="top:316.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">other languages. However, there is no evidence of a systematic bias</span></p>
<p style="top:327.5pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">when non-English articles are excluded.</span><sup><span style="font-family:AdvPS43EDDE,serif;font-size:6.3pt">73</span></sup></p>
<p style="top:351.5pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Conclusion</span></p>
<p style="top:367.9pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">There is a dissociation in the ef&#xfb01;cacy of vitamin C as a neuropro-</span></p>
<p style="top:378.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">tective therapy between pre-clinical and clinical studies. The neutral</span></p>
<p style="top:389.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">effect observed in human studies may be explained by a marked</span></p>
<p style="top:400.8pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">difference in dosing regimens, whereby the median dose in animal</span></p>
<p style="top:411.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">studies has been 10-fold greater than in human trials. Human studies</span></p>
<p style="top:422.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">using pre-clinical doses of parenteral vitamin C appear desirable.</span></p>
<p style="top:446.6pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Funding Information</span></p>
<p style="top:463.0pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">This research did not receive any speci&#xfb01;c grant from funding</span></p>
<p style="top:474.0pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">agencies in the public, commercial, or not-for-pro&#xfb01;t sectors.</span></p>
<p style="top:497.9pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">Author Disclosure Statement</span></p>
<p style="top:514.3pt;left:69.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">No competing &#xfb01;nancial interests exist.</span></p>
<p style="top:536.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">References</span></p>
<p style="top:552.5pt;left:63.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">1. Hill, A., Wendt, S., Benstoem, C., Neubauer, C., Meybohm, P.,</span></p>
<p style="top:561.5pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Langlois, P., Adhikari, N.K., Heyland, D.K., and Stoppe, C. (2018).</span></p>
<p style="top:570.4pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Vitamin C to improve organ dysfunction in cardiac surgery patients-</span></p>
<p style="top:579.4pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">review and pragmatic approach. Nutrients 10, 974.</span></p>
<p style="top:588.4pt;left:63.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">2. Nualart, F., Mack, L., Garcia, A., Cisternas, P., Bongarzone, E.R.,</span></p>
<p style="top:597.3pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Heitzer, M., Jara, N., Martinez, F., Ferrada, L., Espinoza, F., Baeza,</span></p>
<p style="top:606.3pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">V., and Salazar, K. (2014). Vitamin C transporters, recycling and the</span></p>
<p style="top:615.3pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">bystander effect in the nervous system: SVCT2 versus Gluts. J. Stem</span></p>
<p style="top:624.2pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Cell Res. Ther. 4, 209.</span></p>
<p style="top:633.2pt;left:63.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">3. Mandl, J., Szarka, A., and Banhegyi, G. (2009). Vitamin C: update on</span></p>
<p style="top:642.2pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">physiology and pharmacology. Br. J. Pharmacol. 157, 1097&#x2013;1110.</span></p>
<p style="top:651.2pt;left:63.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">4. Harrison, F.E., and May, J.M. (2009). Vitamin C function in the brain:</span></p>
<p style="top:660.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med.</span></p>
<p style="top:669.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">46, 719&#x2013;730.</span></p>
<p style="top:678.0pt;left:63.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">5. Rice, M.E., Lee, E.J., and Choy, Y. (1995). High levels of ascorbic acid,</span></p>
<p style="top:687.0pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">not glutathione, in the CNS of anoxia-tolerant reptiles contrasted with</span></p>
<p style="top:695.9pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">levels in anoxia-intolerant species. J. Neurochem. 64, 1790&#x2013;1799.</span></p>
<p style="top:705.0pt;left:63.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">6. Spoelstra-de Man, A.M., Elbers, P.W., and Oudemans-van Straaten,</span></p>
<p style="top:713.9pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">H.M. (2018). Making sense of early high-dose intravenous vitamin C</span></p>
<p style="top:722.9pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">in ischemia/reperfusion injury, in:</span><span style="font-family:AdvPS47C5ED,serif;font-size:8.0pt"> Annual Update in Intensive Care</span></p>
<p style="top:59.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:8.0pt">and Emergency Medicine 2018</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">. J.L. Vincent (ed). Springer Interna-</span></p>
<p style="top:68.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">tional, Cham, Switzerland, pps. 125&#x2013;139.</span></p>
<p style="top:77.4pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">7. Cherubini, A., Polidori, M.C., Bregnocchi, M., Pezzuto, S., Cecchetti, R.,</span></p>
<p style="top:86.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Ingegni, T., di Iorio, A., Senin, U., and Mecocci, P. (2000). Antioxidant</span></p>
<p style="top:95.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">pro&#xfb01;le and early outcome in stroke patients. Stroke 31, 2295&#x2013;2300.</span></p>
<p style="top:104.3pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">8. Polidori, M.C., Mecocci, P., and Frei, B. (2001). Plasma vitamin C</span></p>
<p style="top:113.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">levels are decreased and correlated with brain damage in patients with</span></p>
<p style="top:122.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">intracranial hemorrhage or head trauma. Stroke 32, 898&#x2013;902.</span></p>
<p style="top:131.2pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">9. Bayir, H., Kagan, V.E., Tyurina, Y.Y., Tyurin, V., Ruppel, R.A.,</span></p>
<p style="top:140.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Adelson, P.D., Graham, S.H., Janesko, K., Clark, R.S., and Kochanek,</span></p>
<p style="top:149.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">P.M. (2002). Assessment of antioxidant reserves and oxidative stress</span></p>
<p style="top:158.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">in cerebrospinal &#xfb02;uid after severe traumatic brain injury in infants and</span></p>
<p style="top:167.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">children. Pediatr. Res. 51, 571&#x2013;578.</span></p>
<p style="top:176.0pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">10. Polidori, M.C., Frei, B., Rordorf, G., Ogilvy, C.S., Koroshetz, W.J.,</span></p>
<p style="top:185.0pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and Beal, M.F. (1997). Increased levels of plasma cholesteryl ester</span></p>
<p style="top:193.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">hydroperoxides in patients with subarachnoid hemorrhage. Free Radic.</span></p>
<p style="top:202.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Biol. Med. 23, 762&#x2013;767.</span></p>
<p style="top:211.9pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">11. Hanafy, K.A., and Selim, M.H. (2012). Antioxidant strategies in</span></p>
<p style="top:220.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">neurocritical care. Neurotherapeutics 9, 44&#x2013;55.</span></p>
<p style="top:229.8pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">12. Spoelstra-de Man, A.M.E., Elbers, P.W.G., and Oudemans-van</span></p>
<p style="top:238.8pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Straaten, H.M. (2018). Making sense of early high-dose intravenous</span></p>
<p style="top:247.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">vitamin C in ischemia/reperfusion injury. Crit. Care 22, 70.</span></p>
<p style="top:256.7pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">13. Nauman, G., Gray, J.C., Parkinson, R., Levine, M., and Paller, C.J.</span></p>
<p style="top:265.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">(2018). Systematic review of intravenous ascorbate in cancer clinical</span></p>
<p style="top:274.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">trials. Antioxidants (Basel) 7, 89.</span></p>
<p style="top:283.6pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">14. Putzu, A., Daems, A.M., Lopez-Delgado, J.C., Giordano, V.F., and</span></p>
<p style="top:292.6pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Landoni, G. (2019). The effect of vitamin C on clinical outcome in</span></p>
<p style="top:301.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">critically ill patients: a systematic review with meta-analysis of ran-</span></p>
<p style="top:310.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">domized controlled trials. Crit. Care Med. 47, 774&#x2013;783.</span></p>
<p style="top:319.5pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">15. Tricco,A.C.,Lillie,E.,Zarin,W.,O&#x2019;Brien,K.K.,Colquhoun,H.,Levac,D.,</span></p>
<p style="top:328.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Moher, D., Peters, M.D.J., Horsley, T., Weeks, L., Hempel, S., Akl, E.A.,</span></p>
<p style="top:337.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson,</span></p>
<p style="top:346.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">M.G., Garritty, C., Lewin, S., Godfrey, C.M., Macdonald, M.T., Langlois,</span></p>
<p style="top:355.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">E.V., Soares-Weiser, K., Moriarty, J., Clifford, T., Tuncalp, O., and Straus,</span></p>
<p style="top:364.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">S.E. (2018). PRISMA Extension for Scoping Reviews (PRISMA-ScR):</span></p>
<p style="top:373.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">checklist and explanation. Ann. Intern. Med. 169, 467&#x2013;473.</span></p>
<p style="top:382.3pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">16. Hooijmans, C.R., Rovers, M.M., de Vries, R.B., Leenaars, M.,</span></p>
<p style="top:391.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE&#x2019;s risk</span></p>
<p style="top:400.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">of bias tool for animal studies. BMC Med. Res. Methodol. 14, 43.</span></p>
<p style="top:409.1pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">17. Sterne, J.A.C., Savovic, J., Page, M.J., Elbers, R.G., Blencowe, N.S.,</span></p>
<p style="top:418.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Boutron, I., Cates, C.J., Cheng, H.Y., Corbett, M.S., Eldridge, S.M.,</span></p>
<p style="top:427.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Emberson, J.R., Hernan, M.A., Hopewell, S., Hrobjartsson, A., Jun-</span></p>
<p style="top:436.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">queira, D.R., Juni, P., Kirkham, J.J., Lasserson, T., Li, T., McAleenan,</span></p>
<p style="top:445.0pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">A., Reeves, B.C., Shepperd, S., Shrier, I., Stewart, L.A., Tilling, K.,</span></p>
<p style="top:454.0pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">White, I.R., Whiting, P.F., and Higgins, J.P.T. (2019). RoB 2: a revised</span></p>
<p style="top:462.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">tool for assessing risk of bias in randomised trials. BMJ 366, l4898.</span></p>
<p style="top:471.9pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">18. Sterne, J.A., Hernan, M.A., Reeves, B.C., Savovic, J., Berkman, N.D.,</span></p>
<p style="top:480.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Viswanathan, M., Henry, D., Altman, D.G., Ansari, M.T., Boutron, I.,</span></p>
<p style="top:489.8pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Carpenter, J.R., Chan, A.W., Churchill, R., Deeks, J.J., Hrobjartsson,</span></p>
<p style="top:498.8pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">A., Kirkham, J., Juni, P., Loke, Y.K., Pigott, T.D., Ramsay, C.R.,</span></p>
<p style="top:507.8pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Regidor, D., Rothstein, H.R., Sandhu, L., Santaguida, P.L., Schune-</span></p>
<p style="top:516.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">mann, H.J., Shea, B., Shrier, I., Tugwell, P., Turner, L., Valentine,</span></p>
<p style="top:525.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">J.C., Waddington, H., Waters, E., Wells, G.A., Whiting, P.F., and</span></p>
<p style="top:534.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Higgins, J.P. (2016). ROBINS-I: a tool for assessing risk of bias in</span></p>
<p style="top:543.6pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">non-randomised studies of interventions. BMJ 355, i4919.</span></p>
<p style="top:552.6pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">19. Miura, S., Ishida, A., Nakajima, W., Ohmura, A., Kawamura, M., and</span></p>
<p style="top:561.6pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Takada, G. (2006). Intraventricular ascorbic acid administration de-</span></p>
<p style="top:570.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">creases hypoxic-ischemic brain injury in newborn rats. Brain Res.</span></p>
<p style="top:579.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">1095, 159&#x2013;166.</span></p>
<p style="top:588.5pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">20. Miura, S., Ishida-Nakajima, W., Ishida, A., Kawamura, M., Ohmura, A.,</span></p>
<p style="top:597.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Oguma, R., Sato, Y., and Takahashi, T. (2009). Ascorbic acid protects</span></p>
<p style="top:606.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">the newborn rat brain from hypoxic-ischemia. Brain Dev. 31, 307&#x2013;317.</span></p>
<p style="top:615.4pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">21. Peeling, J., Yan, H.J., Chen, S.G., Campbell, M., and Del Bigio, M.R.</span></p>
<p style="top:624.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">(1998). Protective effects of free radical inhibitors in intracerebral</span></p>
<p style="top:633.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">hemorrhage in rat. Brain Res. 795, 63&#x2013;70.</span></p>
<p style="top:642.3pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">22. Allahtavakoli, M., Amin, F., Esmaeeli-Nadimi, A., Shamsizadeh, A.,</span></p>
<p style="top:651.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Kazemi-Arababadi, M., and Kennedy, D. (2015). Ascorbic acid re-</span></p>
<p style="top:660.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">duces the adverse effects of delayed administration of tissue plas-</span></p>
<p style="top:669.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">minogen activator in a rat stroke model. Basic Clin. Pharmacol.</span></p>
<p style="top:678.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Toxicol. 117, 335&#x2013;339.</span></p>
<p style="top:687.1pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">23. Bemeur, C., Ste-Marie, L., Desjardins, P., Vachon, L., Butterworth,</span></p>
<p style="top:696.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">R.F., Hazell, A.S., and Montgomery, J. (2005). Dehydroascorbic acid</span></p>
<p style="top:705.0pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">normalizes several markers of oxidative stress and in&#xfb02;ammation in</span></p>
<p style="top:714.0pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">acute hyperglycemic focal cerebral ischemia in the rat. Neurochem.</span></p>
<p style="top:723.0pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Int. 46, 399&#x2013;407.</span></p>
<p style="top:35.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">NEUROPROTECTIVE PROPERTIES OF VITAMIN C</span></p>
<p style="top:35.1pt;left:530.1pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2203</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:59.4pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">24. Corbett, A.M., Sieber, S., Wyatt, N., Lizzi, J., Flannery, T., Sibbit, B.,</span></p>
<p style="top:68.4pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and Sanghvi, S. (2015). Increasing neurogenesis with &#xfb02;uoxetine,</span></p>
<p style="top:77.4pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">simvastatin and ascorbic acid leads to functional recovery in ischemic</span></p>
<p style="top:86.4pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">stroke. Recent Pat. Drug Deliv. Formul. 9, 158&#x2013;166.</span></p>
<p style="top:95.3pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">25. De Sales, K.P.F., Pinto, B.A.S., Ribeiro, N.L.X., Melo, T.M., Galvao-</span></p>
<p style="top:104.3pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Moreira, L.V., De Brito Filho, S.B., and Nigri, F. (2019). Effects of</span></p>
<p style="top:113.2pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">vitamin C on the prevention of ischemia-reperfusion brain injury:</span></p>
<p style="top:122.2pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">experimental study in rats. Int. J. Vasc. Med. 2019, 4090549.</span></p>
<p style="top:131.2pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">26. Ekici, F., Ozyurt, B., and Erdogan, H. (2009). The combination of</span></p>
<p style="top:140.1pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">vitamin D</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">inf</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&gt;</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">3</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">/inf</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&gt;</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> and dehydroascorbic acid administration at-</span></p>
<p style="top:149.1pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">tenuates brain damage in focal ischemia. Neurol. Sci. 30, 207&#x2013;212.</span></p>
<p style="top:158.1pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">27. Henry, P.T., and Chandy, M.J. (1998). Effect of ascorbic acid on</span></p>
<p style="top:167.1pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">infarct size in experimental focal cerebral ischaemia and reperfusion</span></p>
<p style="top:176.0pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">in a primate model. Acta Neurochir. 140, 977&#x2013;980.</span></p>
<p style="top:185.0pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">28. Sinha, J., Das, N., and Basu, M.K. (2001). Liposomal antioxidants in</span></p>
<p style="top:193.9pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">combating ischemia-reperfusion injury in rat brain. Biomed. Phar-</span></p>
<p style="top:202.9pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">macother. 55, 264&#x2013;271.</span></p>
<p style="top:211.9pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">29. Song, J., Park, J., Kim, J.H., Choi, J.Y., Kim, J.Y., Lee, K.M., and</span></p>
<p style="top:220.9pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Lee, J.E. (2015). Dehydroascorbic acid attenuates ischemic brain</span></p>
<p style="top:229.8pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">edema and neurotoxicity in cerebral ischemia: an in vivo study. Exp.</span></p>
<p style="top:238.8pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Neurobiol. 24, 41&#x2013;54.</span></p>
<p style="top:247.7pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">30. Huang, J., Agus, D.B., Winfree, C.J., Kiss, S., Mack, W.J., McTag-</span></p>
<p style="top:256.7pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">gart, R.A., Choudhri, T.F., Kim, L.J., Mocco, J., Pinsky, D.J., Fox,</span></p>
<p style="top:265.7pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">W.D., Israel, R.J., Boyd, T.A., Golde, D.W., and Connolly, E.S., Jr.</span></p>
<p style="top:274.7pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">(2001). Dehydroascorbic acid, a blood-brain barrier transportable form</span></p>
<p style="top:283.6pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">of vitamin C, mediates potent cerebroprotection in experimental</span></p>
<p style="top:292.6pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">stroke. Proc. Natl. Acad. Sci. U. S. A. 98, 11720&#x2013;11724.</span></p>
<p style="top:301.5pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">31. Mack, W.J., Mocco, J., Ducruet, A.F., Laufer, I., King, R.G., Zhang,</span></p>
<p style="top:310.5pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Y.,</span></p>
<p style="top:310.5pt;left:92.6pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Guo,</span></p>
<p style="top:310.5pt;left:115.2pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">W.,</span></p>
<p style="top:310.5pt;left:133.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Pinsky,</span></p>
<p style="top:310.5pt;left:164.2pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">D.J.</span></p>
<p style="top:310.5pt;left:184.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and</span></p>
<p style="top:310.5pt;left:202.5pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Connolly,</span></p>
<p style="top:310.5pt;left:241.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">E.S.,</span></p>
<p style="top:310.5pt;left:263.3pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Jr.</span></p>
<p style="top:310.5pt;left:278.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">(2006).</span></p>
<p style="top:319.5pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">A cerebroprotective dose of intravenous citrate/sorbitol-stabilized</span></p>
<p style="top:328.5pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">dehydroascorbic acid is correlated with increased cerebral ascorbic</span></p>
<p style="top:337.4pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">acid and inhibited lipid peroxidation after murine reperfused stroke.</span></p>
<p style="top:346.4pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Neurosurgery 59, 383&#x2013;388; discussion, 383&#x2013;388.</span></p>
<p style="top:355.3pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">32. Zamani, M., Katebi, M., Mehdizadeh, M., Kafami, L., Malek, F., and</span></p>
<p style="top:364.3pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Soleimani, M. (2013). Combination therapy with a1 receptor agonist</span></p>
<p style="top:373.2pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and vitamin c improved working memory in a mouse model of global</span></p>
<p style="top:382.3pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">ischemia-reperfusion. Basic Clin. Neurosci. 4, 5&#x2013;10.</span></p>
<p style="top:391.2pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">33. Zamani, M., Soleimani, M., Golab, F., Mohamadzadeh, F., Mehdi-</span></p>
<p style="top:400.2pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">zadeh, M., and Katebi, M. (2013). NeuroProtective effects of adeno-</span></p>
<p style="top:409.1pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">sine receptor agonist coadministration with ascorbic acid on CA1</span></p>
<p style="top:418.1pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">hippocampus in a mouse model of ischemia reperfusion injury. Metab.</span></p>
<p style="top:427.0pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Brain Dis. 28, 367&#x2013;374.</span></p>
<p style="top:436.1pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">34. Kameda, K., Kikkawa, Y., Hirano, M., Matsuo, S., Sasaki, T., and</span></p>
<p style="top:445.0pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Hirano, K. (2012). Combined argatroban and anti-oxidative agents</span></p>
<p style="top:454.0pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">prevents increased vascular contractility to thrombin and other ligands</span></p>
<p style="top:462.9pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">after subarachnoid haemorrhage. Br. J. Pharmacol. 165, 106&#x2013;119.</span></p>
<p style="top:471.9pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">35. Kawakami, M., Kodama, N., and Toda, N. (1991). Suppression of the</span></p>
<p style="top:480.9pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">cerebral vasospastic actions of oxyhemoglobin by ascorbic acid.</span></p>
<p style="top:489.8pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Neurosurgery 28, 33&#x2013;40.</span></p>
<p style="top:498.8pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">36. Li, S., Xue, J., Shi, J., Yin, H., and Zhang, Z. (2011). Combinatorial</span></p>
<p style="top:507.8pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">administration of insulin and vitamin C alleviates the cerebral vaso-</span></p>
<p style="top:516.7pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">spasm after experimental subarachnoid hemorrhage in rabbit. BMC</span></p>
<p style="top:525.7pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Neurosci. 12, 77.</span></p>
<p style="top:534.7pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">37. Ishaq, G.M., Saidu, Y., Bilbis, L.S., Muhammad, S.A., Jinjir, N., and</span></p>
<p style="top:543.6pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Shehu, B.B. (2013). Effects of alpha-tocopherol and ascorbic acid in</span></p>
<p style="top:552.6pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">the severity and management of traumatic brain injury in albino rats. J.</span></p>
<p style="top:561.6pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Neurosci. Rural Pract. 4, 292&#x2013;297.</span></p>
<p style="top:570.5pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">38. Lin, J.L., Huang, Y.H., Shen, Y.C., Huang, H.C.,, and Liu, P.H.</span></p>
<p style="top:579.5pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">(2010). Ascorbic acid prevents blood-brain barrier disruption and</span></p>
<p style="top:588.5pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">sensory de&#xfb01;cit caused by sustained compression of primary somato-</span></p>
<p style="top:597.4pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">sensory cortex. J. Cereb. Blood Flow Metab. 30, 1121&#x2013;1136.</span></p>
<p style="top:606.4pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">39. Maekawa, T., Uchida, T., Nakata-Horiuchi, Y., Kobayashi, H., Ka-</span></p>
<p style="top:615.4pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">wauchi, S., Kinoshita, M., Saitoh, D., and Sato, S. (2020). Oral</span></p>
<p style="top:624.3pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">ascorbic acid 2-glucoside prevents coordination disorder induced via</span></p>
<p style="top:633.3pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">laser-induced shock waves in rat brain. PLoS One 15, e0230774.</span></p>
<p style="top:642.3pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">40. Wang, K.W., Wang, H.K., Chen, H.J., Liliang, P.C., Liang, C.L., Tsai,</span></p>
<p style="top:651.2pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Y.D., Cho, C.L., and Lu, K. (2014). Simvastatin combined with anti-</span></p>
<p style="top:660.2pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">oxidant attenuates the cerebral vascular endothelial in&#xfb02;ammatory re-</span></p>
<p style="top:669.2pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">sponse in a rat traumatic brain injury. Biomed Res. Int. 2014, 910260.</span></p>
<p style="top:678.1pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">41. Polidori, M.C., Pratico, D., Ingegni, T., Mariani, E., Spazzafumo, L.,</span></p>
<p style="top:687.1pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Sindaco, P.D., Cecchetti, R., Yao, Y., Ricci, S., Cherubini, A., Stahl,</span></p>
<p style="top:696.1pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">W., Sies, H., Senin, U., and Mecocci, P. (2005). Effects of vitamin C</span></p>
<p style="top:705.0pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and aspirin in ischemic stroke-related lipid peroxidation: results of the</span></p>
<p style="top:714.0pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke)</span></p>
<p style="top:723.0pt;left:75.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Study. BioFactors 24, 265&#x2013;274.</span></p>
<p style="top:59.5pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">42. Ullegaddi, R., Powers, H.J., and Gariballa, S.E. (2005). Antioxidant</span></p>
<p style="top:68.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">supplementation enhances antioxidant capacity and mitigates oxida-</span></p>
<p style="top:77.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">tive damage following acute ischaemic stroke. Eur. J. Clin. Nutr. 59,</span></p>
<p style="top:86.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">1367&#x2013;1373.</span></p>
<p style="top:95.3pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">43. Ullegaddi, R., Powers, H.J., and Gariballa, S.E. (2006). Antioxidant</span></p>
<p style="top:104.3pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">supplementation with or without B-group vitamins after acute ische-</span></p>
<p style="top:113.3pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">mic stroke: a randomized controlled trial. J. Parenter. Enteral Nutr. 30,</span></p>
<p style="top:122.2pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">108&#x2013;114.</span></p>
<p style="top:131.2pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">44. Rabl, H., Khoschsorur, G., Hauser, H., Petek, W., and Esterbauer, H.</span></p>
<p style="top:140.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">(1996). Diminished production of malondialdehyde after carotid artery</span></p>
<p style="top:149.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">surgery as a result of vitamin administration. Med. Sci. Res. 24, 777&#x2013;780.</span></p>
<p style="top:158.1pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">45. Razmkon, A., Sadidi, A., Sherafat-Kazemzadeh, E., Mehrafshan, A.,</span></p>
<p style="top:167.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Jamali, M., Malekpour, B., and Sagha&#xfb01;nia, M. (2011). Administration</span></p>
<p style="top:176.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">of vitamin C and vitamin E in severe head injury: a randomized</span></p>
<p style="top:185.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">double-blind controlled trial. Clin. Neurosurg. 58, 133&#x2013;137.</span></p>
<p style="top:193.9pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">46. Aly, H., Abd-Rabboh, L., El-Dib, M., Nawwar, F., Hassan, H., Aaref,</span></p>
<p style="top:203.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">M., Abdelrahman, S., and Elsayed, A. (2009). Ascorbic acid combined</span></p>
<p style="top:211.9pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">with ibuprofen in hypoxic ischemic encephalopathy: a randomized</span></p>
<p style="top:220.9pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">controlled trial. J. Perinatol. 29, 438&#x2013;443.</span></p>
<p style="top:229.8pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">47. Kodama, N., Sasaki, T., Kawakami, M., Sato, M., and Asari, J. (2000).</span></p>
<p style="top:238.8pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Cisternal irrigation therapy with urokinase and ascorbic acid for pre-</span></p>
<p style="top:247.7pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">vention of vasospasm after aneurysmal subarachnoid hemorrhage.</span></p>
<p style="top:256.7pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Outcome in 217 patients. Surg. Neurol. 53, 110&#x2013;118.</span></p>
<p style="top:265.7pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">48. Garbagnati, F., Cairella, G., De Martino, A., Multari, M., Scognamiglio,</span></p>
<p style="top:274.7pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">U., Venturiero, V., and Paolucci, S. (2009). Is antioxidant and n-3</span></p>
<p style="top:283.6pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">supplementation able to improve functional status in poststroke patients?</span></p>
<p style="top:292.6pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Results from the nutristroke trial. Cerebrovasc. Dis. 27, 375&#x2013;383.</span></p>
<p style="top:301.5pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">49. Lagowska-Lenard, M., Stelmasiak, Z., and Bartosik-Psujek, H. (2010).</span></p>
<p style="top:310.5pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">In&#xfb02;uence of vitamin C on markers of oxidative stress in the earliest</span></p>
<p style="top:319.5pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">period of ischemic stroke. Pharmacol. Rep. 62, 751&#x2013;756.</span></p>
<p style="top:328.5pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">50. Rabadi, M.H., and Kristal, B.S. (2007). Effect of vitamin C supple-</span></p>
<p style="top:337.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">mentation on stroke recovery: a case-control study. Clin. Interv. Aging</span></p>
<p style="top:346.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">2, 147&#x2013;151.</span></p>
<p style="top:355.3pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">51. Rumyantseva, S.A., Kovalenko, A.L., Silina, E.V., Stupin, V.A.,</span></p>
<p style="top:364.3pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Kabaeva, E.N., Chichanovskaya, L.V., Nazarov, M.V., Tsukurova,</span></p>
<p style="top:373.3pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">L.A., Burenichev, D.V., Golikov, K.V., Sal&#x2019;nikov, M.V., Belova,</span></p>
<p style="top:382.3pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">L.A., Mashin, V.V., Mazina, N.K., Zhilina, E.A., Kolotik-Kameneva,</span></p>
<p style="top:391.2pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">O.Y., and Sherman, M.A. (2017). Ef&#xfb01;cacy of complex antioxidant</span></p>
<p style="top:400.2pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">energy correction of different durations in the treatment of cerebral</span></p>
<p style="top:409.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">infarction (results of a multicenter randomized study). Neurosci. Be-</span></p>
<p style="top:418.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">hav. Physiol. 47, 288&#x2013;295.</span></p>
<p style="top:427.1pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">52. Kodama, N., Sasaki, T., Matsumoto, M., Suzuki, K., Sakuma, J.,</span></p>
<p style="top:436.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Endo, Y., Oinuma, M., Ishikawa, T., and Sato, T. (2008). Prevention</span></p>
<p style="top:445.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">of symptomatic vasospasm&#x2014;effect of continuous cisternal irrigation</span></p>
<p style="top:454.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">with urokinase and ascorbic acid, in:</span><span style="font-family:AdvPS47C5ED,serif;font-size:8.0pt"> Cerebral Vasospasm: New</span></p>
<p style="top:463.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:8.0pt">Strategies in Research and Treatment</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">. T. K&#x131;r&#x131;s</span><span style="font-family:AdvPS97F5,serif;font-size:8.0pt">x</span><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt"> and J.H. Zhang (eds).</span></p>
<p style="top:471.9pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Springer-Verlag: Vienna, Austria, pps. 325&#x2013;327.</span></p>
<p style="top:480.9pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">53. Dorsch, N.W., and King, M.T. (1994). A review of cerebral vaso-</span></p>
<p style="top:489.8pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">spasm in aneurysmal subarachnoid haemorrhage part I: incidence and</span></p>
<p style="top:498.8pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">effects. J. Clin. Neurosci. 1, 19&#x2013;26.</span></p>
<p style="top:507.8pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">54. Carr, A.C., Rosengrave, P.C., Bayer, S., Chambers, S., Mehrtens, J.,</span></p>
<p style="top:516.8pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and Shaw, G.M. (2017). Hypovitaminosis C and vitamin C de&#xfb01;ciency</span></p>
<p style="top:525.7pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">in critically ill patients despite recommended enteral and parenteral</span></p>
<p style="top:534.7pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">intakes. Crit. Care 21, 300.</span></p>
<p style="top:543.6pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">55. Rumelin, A., Jaehde, U., Kerz, T., Roth, W., Kramer, M., and Fauth,</span></p>
<p style="top:552.6pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">U. (2005). Early postoperative substitution procedure of the antioxi-</span></p>
<p style="top:561.6pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">dant ascorbic acid. J. Nutr. Biochem. 16, 104&#x2013;108.</span></p>
<p style="top:570.6pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">56. Fowler, A.A., 3rd, Syed, A.A., Knowlson, S., Sculthorpe, R., Farthing,</span></p>
<p style="top:579.5pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">D., DeWilde, C., Farthing, C.A., Larus, T.L., Martin, E., Brophy, D.F.,</span></p>
<p style="top:588.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Gupta, S., Medical Respiratory Intensive Care Unit, N., Fisher, B.J.,</span></p>
<p style="top:597.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and Natarajan, R. (2014). Phase I safety trial of intravenous ascorbic</span></p>
<p style="top:606.4pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">acid in patients with severe sepsis. J. Transl. Med. 12, 32.</span></p>
<p style="top:615.4pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">57. Hudson, E.P., Collie, J.T., Fujii, T., Luethi, N., Udy, A.A., Doherty, S.,</span></p>
<p style="top:624.3pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Eastwood, G., Yanase, F., Naorungroj, T., Bitker, L., Abdelhamid, Y.A.,</span></p>
<p style="top:633.3pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Greaves, R.F., Deane, A.M., and Bellomo, R. (2019). Pharmacokinetic</span></p>
<p style="top:642.2pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">data support 6-hourly dosing of intravenous vitamin C to critically ill</span></p>
<p style="top:651.2pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">patients with septic shock. Crit. Care Resusc. 21, 236&#x2013;242.</span></p>
<p style="top:660.2pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">58. de Grooth, H.J., Manubulu-Choo, W.P., Zandvliet, A.S., Spoelstra-de</span></p>
<p style="top:669.2pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Man, A.M.E., Girbes, A.R., Swart, E.L., and Oudemans-van Straaten,</span></p>
<p style="top:678.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">H.M. (2018). Vitamin C pharmacokinetics in critically ill patients: a</span></p>
<p style="top:687.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">randomized trial of four IV regimens. Chest 153, 1368&#x2013;1377.</span></p>
<p style="top:696.1pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">59. McNamara, R., Deane, A.M., Anstey, J., and Bellomo, R. (2018).</span></p>
<p style="top:705.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Understanding the rationale for parenteral ascorbate (vitamin C)</span></p>
<p style="top:714.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">during an acute in&#xfb02;ammatory reaction: a biochemical perspective.</span></p>
<p style="top:723.0pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Crit. Care Resusc. 20, 174&#x2013;179.</span></p>
<p style="top:35.2pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2204</span></p>
<p style="top:35.2pt;left:467.0pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">KANGISSER ET AL.</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>


<p style="top:59.4pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">60. Duconge, J., Miranda-Massari, J.R., Gonzalez, M.J., Jackson, J.A.,</span></p>
<p style="top:68.4pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Warnock, W., and Riordan, N.H. (2008). Pharmacokinetics of vitamin</span></p>
<p style="top:77.4pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">C: insights into the oral and intravenous administration of ascorbate.</span></p>
<p style="top:86.4pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">P. R. Health Sci. J 27, 7&#x2013;19.</span></p>
<p style="top:95.3pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">61. Blanchard, J., Tozer, T.N., and Rowland, M. (1997). Pharmacokinetic</span></p>
<p style="top:104.3pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">perspectives on megadoses of ascorbic acid. Am. J. Clin. Nutr. 66,</span></p>
<p style="top:113.2pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">1165&#x2013;1171.</span></p>
<p style="top:122.2pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">62. Wernerman, J., Christopher, K.B., Annane, D., Casaer, M.P., Coop-</span></p>
<p style="top:131.2pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">ersmith, C.M., Deane, A.M., De Waele, E., Elke, G., Ichai, C., Kar-</span></p>
<p style="top:140.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">vellas,</span></p>
<p style="top:140.1pt;left:102.3pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">C.J.,</span></p>
<p style="top:140.1pt;left:124.6pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">McClave,</span></p>
<p style="top:140.1pt;left:163.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">S.A.,</span></p>
<p style="top:140.1pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Oudemans-van</span></p>
<p style="top:140.1pt;left:244.0pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Straaten,</span></p>
<p style="top:140.1pt;left:280.2pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">H.M.,</span></p>
<p style="top:149.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Rooyackers, O., Stapleton, R.D., Takala, J., van Zanten, A.R.H.,</span></p>
<p style="top:158.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Wischmeyer, P.E., Preiser, J.C., and Vincent, J.L. (2019). Metabolic</span></p>
<p style="top:167.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">support in the critically ill: a consensus of 19. Crit. Care 23, 318.</span></p>
<p style="top:176.0pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">63. Agus, D.B., Gambhir, S.S., Pardridge, W.M., Spielholz, C., Baselga,</span></p>
<p style="top:185.0pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">J., Vera, J.C., and Golde, D.W. (1997). Vitamin C crosses the blood-</span></p>
<p style="top:193.9pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">brain barrier in the oxidized form through the glucose transporters. J.</span></p>
<p style="top:202.9pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Clin. Invest. 100, 2842&#x2013;2848.</span></p>
<p style="top:211.9pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">64. Menon, D.K. (2009). Unique challenges in clinical trials in traumatic</span></p>
<p style="top:220.9pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">brain injury. Crit. Care Med. 37, 1 Suppl., S129&#x2013;S135.</span></p>
<p style="top:229.8pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">65. Leichtle, S.W., Sarma, A.K., Strein, M., Yajnik, V., Rivet, D., Sima, A.,</span></p>
<p style="top:238.8pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">and Brophy, G.M. (2020). High-dose intravenous ascorbic acid: ready</span></p>
<p style="top:247.7pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">for prime time in traumatic brain injury? Neurocrit. Care 32, 333&#x2013;339.</span></p>
<p style="top:256.7pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">66. Fujii, T., Luethi, N., Young, P.J., Frei, D.R., Eastwood, G.M., French,</span></p>
<p style="top:265.7pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">C.J., Deane, A.M., Shehabi, Y., Hajjar, L.A., Oliveira, G., Udy, A.A.,</span></p>
<p style="top:274.7pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Orford, N., Edney, S.J., Hunt, A.L., Judd, H.L., Bitker, L., Cioccari, L.,</span></p>
<p style="top:283.6pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Naorungroj, T., Yanase, F., Bates, S., McGain, F., Hudson, E.P., Al-</span></p>
<p style="top:292.6pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Bassam, W., Dwivedi, D.B., Peppin, C., McCracken, P., Orosz, J.,</span></p>
<p style="top:301.5pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Bailey, M., Bellomo, R., and Investigators, V.T. (2020). Effect of vi-</span></p>
<p style="top:310.5pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">tamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time</span></p>
<p style="top:319.5pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">alive and free of vasopressor support among patients with septic shock:</span></p>
<p style="top:328.5pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">the VITAMINS Randomized Clinical Trial. JAMA 323, 423&#x2013;431.</span></p>
<p style="top:337.4pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">67. Moskowitz, A., Huang, D.T., Hou, P.C., Gong, J., Doshi, P.B., Gros-</span></p>
<p style="top:346.4pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">sestreuer, A.V., Andersen, L.W., Ngo, L., Sherwin, R.L., Berg, K.M.,</span></p>
<p style="top:355.3pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Chase, M., Cocchi, M.N., McCannon, J.B., Hershey, M., Hilewitz, A.,</span></p>
<p style="top:364.3pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Korotun, M., Becker, L.B., Otero, R.M., Uduman, J., Sen, A., and</span></p>
<p style="top:373.2pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Donnino, M.W.; ACTS Clinical Trial Investigators. (2020). Effect of</span></p>
<p style="top:382.3pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">ascorbic acid, corticosteroids, and thiamine on organ injury in septic</span></p>
<p style="top:391.2pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">shock: the ACTS Randomized Clinical Trial. JAMA 324, 642&#x2013;650.</span></p>
<p style="top:400.2pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">68. Hwang, S.Y., Ryoo, S.M., Park, J.E., Jo, Y.H., Jang, D.H., Suh, G.J.,</span></p>
<p style="top:409.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Kim, T., Kim, Y.J., Kim, S., Cho, H., Jo, I.J., Chung, S.P., Choi, S.H.,</span></p>
<p style="top:418.1pt;left:73.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Shin, T.G., Kim, W.Y., and Korean Shock Society (KoSS). (2020).</span></p>
<p style="top:59.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Combination therapy of vitamin C and thiamine for septic shock: a</span></p>
<p style="top:68.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">multi-centre, double-blinded randomized, controlled study. Intensive</span></p>
<p style="top:77.4pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Care Med. doi: 10.1007/s00134-020-06191-3.</span></p>
<p style="top:86.4pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">69. Fowler, A.A. III, Truwit, J.D., Hite, R.D., Morris, P.E., DeWilde, C.,</span></p>
<p style="top:95.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Priday, A., Fisher, B., Thacker, L.R. II, Natarajan, R., Brophy, D.F.,</span></p>
<p style="top:104.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Sculthorpe, R., Nanchal, R., Syed, A., Sturgill, J., Martin, G.S., Sev-</span></p>
<p style="top:113.3pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">ransky, J., Kashiouris, M., Hamman, S., Egan, K.F., Hastings, A.,</span></p>
<p style="top:122.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Spencer, W., Tench, S., Mehkri, O., Bindas, J., Duggal, A., Graf, J.,</span></p>
<p style="top:131.2pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Zellner, S., Yanny, L., McPolin, C., Hollrith, T., Kramer, D., Ojielo,</span></p>
<p style="top:140.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">C., Damm, T., Cassity, E., Wieliczko, A., and Halquist, M. (2019).</span></p>
<p style="top:149.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Effect of vitamin C infusion on organ failure and biomarkers of in-</span></p>
<p style="top:158.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">&#xfb02;ammation and vascular injury in patients with sepsis and severe acute</span></p>
<p style="top:167.1pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">respiratory failure: the CITRIS-ALI Randomized Clinical Trial.</span></p>
<p style="top:176.0pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">JAMA 322, 1261&#x2013;1270.</span></p>
<p style="top:185.0pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">70. Lankadeva, Y.R., Peiris, R.M., Okazaki, N., Birchall, I.E., Trask-</span></p>
<p style="top:193.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Marino, A., Dornom, A., Vale, T.A.M., Evans, R.G., Yanase, F.,</span></p>
<p style="top:202.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Bellomo, R., and May, C.N. (2021). Reversal of the pathophysiolog-</span></p>
<p style="top:211.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">ical responses to Gram-negative sepsis by megadose vitamin C. Crit.</span></p>
<p style="top:220.9pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Care Med. 49, e179&#x2013;e190.</span></p>
<p style="top:229.8pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">71. Marklund, N., and Hillered, L. (2011). Animal modelling of traumatic</span></p>
<p style="top:238.8pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">brain injury in preclinical drug development: where do we go from</span></p>
<p style="top:247.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">here? Br. J. Pharmacol. 164, 1207&#x2013;1229.</span></p>
<p style="top:256.7pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">72. Pound, P. and Ritskes-Hoitinga, M. (2018). Is it possible to overcome</span></p>
<p style="top:265.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">issues of external validity in preclinical animal research? Why most</span></p>
<p style="top:274.7pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">animal models are bound to fail. J. Transl. Med. 16, 304.</span></p>
<p style="top:283.6pt;left:310.8pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">73. Morrison, A., Polisena, J., Husereau, D., Moulton, K., Clark, M.,</span></p>
<p style="top:292.6pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Fiander, M., Mierzwinski-Urban, M., Clifford, T., Hutton, B., and</span></p>
<p style="top:301.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">Rabb, D. (2012). The effect of English-language restriction on sys-</span></p>
<p style="top:310.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">tematic review-based meta-analyses: a systematic review of empirical</span></p>
<p style="top:319.5pt;left:324.7pt;line-height:8.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:8.0pt">studies. Int. J. Technol. Assess. Health Care 28, 138&#x2013;144.</span></p>
<p style="top:335.1pt;left:448.7pt;line-height:9.0pt"><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt">Address correspondence to:</span></p>
<p style="top:346.1pt;left:462.3pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Mark P. Plummer, PhD</span></p>
<p style="top:357.0pt;left:440.7pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Department of Intensive Care</span></p>
<p style="top:368.0pt;left:452.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Royal Melbourne Hospital</span></p>
<p style="top:379.0pt;left:481.1pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">300 Grattan Street</span></p>
<p style="top:389.9pt;left:461.2pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Parkville, Victoria 3050</span></p>
<p style="top:400.8pt;left:516.5pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">Australia</span></p>
<p style="top:417.3pt;left:421.6pt;line-height:9.0pt"><span style="font-family:AdvPS47C5ED,serif;font-size:9.0pt">E-mail:</span><span style="font-family:AdvPS43EDDE,serif;font-size:9.0pt"> mark.plummer@mh.org.au</span></p>
<p style="top:35.1pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">NEUROPROTECTIVE PROPERTIES OF VITAMIN C</span></p>
<p style="top:35.1pt;left:530.1pt;line-height:9.0pt"><span style="font-family:AdvP6EC5,serif;font-size:9.0pt">2205</span></p>
<p style="top:557.8pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Karolinska Institutet University Library from www.liebertpub.com at 03/02/23. For personal use only. </span></p>

</div>
